EurekaMag PDF full texts Chapter 12,627

Kalueff, A.; Loseva, E.; Haapasalo, H.; Rantala, I.; Keranen, J.; Lou, Y.-R.; Minasyan, A.; Keisala, T.; Miettinen, S.; Kuuslahti, M.; Tuchimaa, P. 2006: Thalamic calcification in vitamin D receptor knockout mice. Neuroreport 17(7): 717-721

Molnar, G.F.; Sailer, A.; Gunraj, C.A.; Lang, A.E.; Lozano, A.M.; Chen, R. 2004: Thalamic deep brain stimulation activates the cerebellothalamocortical pathway. Neurology 63(5): 907-909

Putzke, J.D.; Wharen, R.E.; Obwegeser, A.A.; Wszolek, Z.K.; Lucas, J.A.; Turk, M.F.; Uitti, R.J. 2004: Thalamic deep brain stimulation for essential tremor: recommendations for long-term outcome analysis. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 31(3): 333-342

Lee, J.Y.K.; Kondziolka, D. 2005: Thalamic deep brain stimulation for management of essential tremor. Journal of Neurosurgery 103(3): 400-403

Vieira, C.; Garda, A-Lila.; Shimamura, K.; Martinez, S. 2005: Thalamic development induced by Shh in the chick embryo. Developmental Biology 284(2): 351-363

Glendenning, K.K. 2006: Thalamic development of the gray short-tailed opossum (Monodelphis domestica). Journal of Mammalogy 87(3): 554-562

Mory, S.B.; Li, L.M.; Guerreiro, C.A.M.; Cendes, F. 2003: Thalamic dysfunction in juvenile myoclonic epilepsy: a proton MRS study. Epilepsia 44(11): 1402-1405

Clinton, S.M.; Meador-Woodruff, J.H. 2004: Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities. Schizophrenia Research 69(2-3): 237-253

Colnat-Coulbois, S.; Marchal, J.C. 2005: Thalamic ependymal cyst presenting with tremor. Child's Nervous System: Chns: Official Journal of the International Society for Pediatric Neurosurgery 21(10): 933-935

Ji, Y.-Cheol; Suk, J.-Sik; Hong, H.-Jong; Kwon, J.-Taik; Kim, Y.-Baeg 2004: Thalamic hemorrhage and pure sensory stroke: Case report. Chung Ang Journal of Medicine 29(3-4): 113-115

Soyka, M.; Koch, W.; Tatsch, K. 2005: Thalamic hypofunction in alcohol hallucinosis: FDG PET findings. Psychiatry Research 139(3): 259-262

Lee, P.H.; Lee, J.H.; Joo, U.S. 2005: Thalamic infarct presenting with thalamic astasia. European Journal of Neurology 12(4): 317-319

Dieterich, M.; Bartenstein, P.; Spiegel, S.; Bense, S.; Schwaiger, M.; Brandt, T. 2005: Thalamic infarctions cause side-specific suppression of vestibular cortex activations. Brain: a Journal of Neurology 128(Pt 9): 2052-2067

Lanciego, J.é L.; Gonzalo, N.; Castle, M.; Sanchez-Escobar, C.; Aymerich, M.S.; Obeso, J.A. 2004: Thalamic innervation of striatal and subthalamic neurons projecting to the rat entopeduncular nucleus. European Journal of Neuroscience 19(5): 1267-1277

Castle, M.; Aymerich, M.S.; Sanchez-Escobar, C.; Gonzalo, N.; Obeso, J.é A.; Lanciego, J.é L. 2005: Thalamic innervation of the direct and indirect basal ganglia pathways in the rat: Ipsi- and contralateral projections. Journal of Comparative Neurology 483(2): 143-153

Rüb, U.; Del Turco, D.; Del Tredici, K.; de Vos, R.A.I.; Brunt, E.R.; Reifenberger, G.; Seifried, C.; Schultz, C.; Auburger, G.; Braak, H. 2003: Thalamic involvement in a spinocerebellar ataxia type 2 (SCA2) and a spinocerebellar ataxia type 3 (SCA3) patient, and its clinical relevance. Brain: a Journal of Neurology 126(Pt 10): 2257-2272

Ito, Y.; Kumada, S.; Uchiyama, A.; Saito, K.; Osawa, M.; Yagishita, A.; Kurata, K.; Hayashi, M. 2004: Thalamic lesions in a long-surviving child with spinal muscular atrophy type I: MRI and EEG findings. Brain and Development 26(1): 53-56

Bastos Leite, Aónio.J.; van Straaten, E.C.W.; Scheltens, P.; Lycklama, G.; Barkhof, F. 2004: Thalamic lesions in vascular dementia: low sensitivity of fluid-attenuated inversion recovery (FLAIR) imaging. Stroke 35(2): 415-419

Saab, C.Y.; Park, Y.C.; Al-Chaer, E.D. 2004: Thalamic modulation of visceral nociceptive processing in adult rats with neonatal colon irritation. Brain Research 1008(2): 186-192

Pessiglione, M.; Guehl, D.; Rolland, A.-S.; François, C.; Hirsch, E.C.; Féger, J.; Tremblay, L.éo. 2005: Thalamic neuronal activity in dopamine-depleted primates: evidence for a loss of functional segregation within basal ganglia circuits. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 25(6): 1523-1531

Hamani, C.; Mello, L., E.A.M. 2002: Thalamic neuropathology in the chronic pilocarpine and picrotoxin model of epilepsy. Thalamus and Related Systems 2(1): 49-53

Pimlott, S.L.; Piggott, M.; Ballard, C.; McKeith, I.; Perry, R.; Kometa, S.; Owens, J.; Wyper, D.; Perry, E. 2006: Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies. Neurobiology of Disease 21(1): 50-56

Wang, J.; Huo, F.-Q.; Li, Y.-Q.; Chen, T.; Han, F.; Tang, J.-S. 2005: Thalamic nucleus submedius receives GABAergic projection from thalamic reticular nucleus in the rat. Neuroscience 134(2): 515-523

Fuentealba, P.; Steriade, M. 2005: Thalamic oscillations modulate membrane properties of cat thalamic reticular neurons. Thalamus and Related Systems 3(1): 53-62

Spencer, S.J.; Fox, J.C.; Day, T.A. 2004: Thalamic paraventricular nucleus lesions facilitate central amygdala neuronal responses to acute psychological stress. Brain Research 997(2): 234-237

Radtke-Schuller, S.; Schuller, G.; O'Neill, W.E. 2004: Thalamic projections to the auditory cortex in the rufous horseshoe bat (Rhinolophus rouxi). II. Dorsal fields. Anatomy and Embryology 209(1): 77-91

Zackheim, J.; Abercrombie, E.D. 2005: Thalamic regulation of striatal acetylcholine efflux is both direct and indirect and qualitatively altered in the dopamine-depleted striatum. Neuroscience 131(2): 423-436

Yamamoto, T.; Katayama, Y.; Obuchi, T.; Kano, T.; Kobayashi, K.; Oshima, H.; Fukaya, C. 2006: Thalamic sensory relay nucleus stimulation for the treatment of peripheral deafferentation pain. Stereotactic and Functional Neurosurgery 84(4): 180-183

Grenier, F.; Timofeev, I.; Steriade, M. 2002: Thalamic short-term plasticity and its impact on the neocortex. Thalamus and Related Systems 1(4): 331-340

Shimojima, Y.; Hashimoto, T.; Kaneko, K.; Yazaki, M.; Yoshida, K.; Goto, T.; Yamada, R.; Hongo, K.; Ikeda, S.-i. 2005: Thalamic stimulation for disabling tremor in a patient with spinocerebellar degeneration. Stereotactic and Functional Neurosurgery 83(4): 131-134

Fukuda, M.; Barnes, A.; Simon, E.S.; Holmes, A.; Dhawan, V.; Giladi, N.; Fodstad, H.; Ma, Y.; Eidelberg, D. 2004: Thalamic stimulation for parkinsonian tremor: correlation between regional cerebral blood flow and physiological tremor characteristics. Neuroimage 21(2): 608-615

Montes, C.; Magnin, M.; Maarrawi, J.; Frot, M.; Convers, P.; Mauguière, Fçois.; Garcia-Larrea, L. 2005: Thalamic thermo-algesic transmission: ventral posterior (VP) complex versus VMpo in the light of a thalamic infarct with central pain. Pain 113(1-2): 223-232

Sarnthein, J.; Morel, A.; Von-Stein, A.; Jeanmonod, D. 2003: Thalamic theta field potentials and EEG: high thalamocortical coherence in patients with neurogenic pain, epilepsy and movement disorders. Thalamus and Related Systems 2(3): 231-238

Preuss, U.W.; Zetzsche, T.; Jäger, M.; Groll, C.; Frodl, T.; Bottlender, R.; Leinsinger, G.; Hegerl, U.; Hahn, K.; Möller, H.J.; Meisenzahl, E.M. 2004: Thalamic volume in first-episode and chronic schizophrenic subjects: a volumetric MRI study. Schizophrenia Research 73(1): 91-101

Matsuzaki, R.; Kyuhou, S-ichi.; Matsuura-Nakao, K.; Gemba, H. 2004: Thalamo-cortical projections to the posterior parietal cortex in the monkey. Neuroscience Letters 355(1-2): 113-116

Carden, W.Breckinridge.; Guido, W.; Godwin, D.W.; Bickford, M.E. 2003: Thalamocortical cells in the cat pulvinar nucleus transiently express nitric oxide synthase during development. Neuroscience Letters 351(2): 87-90

Buchsbaum, M.S.; Buchsbaum, B.R.; Chokron, S.; Tang, C.; Wei, T.-C.; Byne, W. 2006: Thalamocortical circuits: fMRi assessment of the pulvinar and medial dorsal nucleus in normal volunteers. Neuroscience Letters 404(3): 282-287

Zhu, D.; Lustig, K.H.; Bifulco, K.; Keifer, J. 2005: Thalamocortical connections in the pond turtle Pseudemys scripta elegans. Brain Behavior and Evolution 65(4): 278-292

Disbrow, E.; Litinas, E.; Recanzone, G., H.; Slutsky, D.; Krubitzer, L. 2002: Thalamocortical connections of the parietal ventral area (PV) and the second somatosensory area (S2) in macaque monkeys. Thalamus and Related Systems 1(4): 289-302

Biagini, G.; D'antuono, M.; Tancredi, V.; Motalli, R.; Louvel, J.; D'arcangelo, G.; Pumain, R.; Warren, R., A.; Avoli, M. 2001: Thalamocortical connectivity in a rat brain slice preparation: participation of the ventrobasal complex to synchronous activities. Thalamus and Related Systems 1(2): 169-179

Llinas, R.; Ribary, U.; Jeanmonod, D.; Cancro, R.; Kronberg, E.; Schulman, J.; Zonenshayn, M.; Magnin, M.; Morel, A.; Siegmund, M. 2001: Thalamocortical dysrhythmia I. Functional and imaging aspects. Thalamus and Related Systems 1(3): 237-244

Jeanmonod, D.; Magnin, M.; Morel, A.; Siegemund, M.; Cancro, A.; Lanz, M.; Llinas, R.; Ribary, U.; Kronberg, E.; Schulman, J.; Zonenshayn, M. 2001: Thalamocortical dysrhythmia II. Clinical and surgical aspects. Thalamus and Related Systems 1(3): 245-254

Schulman, J., J.; Ramirez, R., R.; Zonenshayn, M.; Ribary, U.; Llinas, R. 2005: Thalamocortical dysrhythmia syndrome: MEG imaging of neuropathic pain. Thalamus and Related Systems 3(1): 33-39

Oda, S.; Kishi, K.; Yang, J.; Chen, S.; Yokofujita, J.; Igarashi, H.; Tanihata, S.; Kuroda, M. 2004: Thalamocortical projection from the ventral posteromedial nucleus sends its collaterals to layer I of the primary somatosensory cortex in rat. Neuroscience Letters 367(3): 394-398

Alonso, J.-M.; Swadlow, H.A. 2005: Thalamocortical specificity and the synthesis of sensory cortical receptive fields. Journal of Neurophysiology 94(1): 26-32

Sarnthein, J.; Morel, A.; von Stein, A.; Jeanmonod, D. 2005: Thalamocortical theta coherence in neurological patients at rest and during a working memory task. International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology 57(2): 87-96

Csillag, A.ás.; Montagnese, C.M. 2005: Thalamotelencephalic organization in birds. Brain Research Bulletin 66(4-6): 303-310

Bentivoglio, M.; Kristensson, K. 2004: Thalamus in flame: targeting of infectious agents to thalamic nuclei. Thalamus and Related Systems 2(4): 297-314

Brickman, A.M.; Buchsbaum, M.S.; Shihabuddin, L.; Byne, W.; Newmark, R.E.; Brand, J.; Ahmed, S.; Mitelman, S.A.; Hazlett, E.A. 2004: Thalamus size and outcome in schizophrenia. Schizophrenia Research 71(2-3): 473-484

Sgourou, A.; Routledge, S.; Antoniou, M.; Papachatzopoulou, A.; Psiouri, L.; Athanassiadou, A. 2004: Thalassaemia mutations within the 5'UTR of the human beta-globin gene disrupt transcription. British Journal of Haematology 124(6): 828-835

Faà, V.; Meloni, A.; Moi, L.; Ibba, G.; Travi, M.; Vitucci, A.; Cao, A.; Rosatelli, M.Cristina. 2006: Thalassaemia-like carriers not linked to the beta-globin gene cluster. British Journal of Haematology 132(5): 640-650

Weatherall, D.J. 2002: Thalassaemia: Towards an understanding of a monogenic disease. ScienceAsia 28(Suppl 1): 35-39

Sarnaik, S.A. 2005: Thalassemia and related hemoglobinopathies. Indian Journal of Pediatrics 72(4): 319-324

Premawardhena, A.; De Silva, S.; Arambepola, M.; Olivieri, N.; Merson, L.; Muraco, J.; Allen, A.; Fisher, C.; Peto, T.; Vichinsky, E.; Weatherall, D. 2004: Thalassemia in Sri Lanka: a progress report. Human Molecular Genetics 13 Spec no 2: R203-R206

Wajcman, H.; Krishnamoorthy, R. 2004: Thalassemia in Tunisia: More tasks ahead. Hemoglobin 28(3): 171-172

Taher, A.; Isma'eel, H.; Cappellini, M.D. 2006: Thalassemia intermedia: revisited. Blood Cells Molecules and Diseases 37(1): 12-20

Borgna-Pignatti, C.; Rigon, F.; Merlo, L.; Chakrok, R.; Micciolo, R.; Perseu, L.; Galanello, R. 2003: Thalassemia minor, the Gilbert mutation, and the risk of gallstones. Haematologica 88(10): 1106-1109

Ngoc-Ho, Nguyen 2005: Thalassinidea (Crustacea, Decapoda) from French Polynesia. Zoosystema 27(1): 47-83

Sunesen, I.; Sar, E., A. 2004: Thalassiosira fryxelliae nov. spec. (Bacillariophyceae) from Argentinian coastal waters. Botanica Marina 47(3): 238-247

Macián, M.C.; Arahal, D.R.; Garay, E.; Ludwig, W.; Schleifer, K.H.; Pujalte, M.J. 2005: Thalassobacter stenotrophicus gen. nov., sp. nov., a novel marine alpha-proteobacterium isolated from Mediterranean sea water. International Journal of Systematic and Evolutionary Microbiology 55(Pt 1): 105-110

Yi, H.; Chun, J. 2006: Thalassobius aestuarii sp. nov., isolated from tidal flat sediment. Journal of Microbiology 44(2): 171-176

Arahal, D.R.; Macián, M.C.; Garay, E.; Pujalte, M.J. 2005: Thalassobius mediterraneus gen. nov., sp. nov., and reclassification of Ruegeria gelatinovorans as Thalassobius gelatinovorus comb. nov. International Journal of Systematic and Evolutionary Microbiology 55(Part 6): 2371-2376

Yakimov, M.M.; Giuliano, L.; Denaro, R.; Crisafi, E.; Chernikova, T.N.; Abraham, W-Rainer.; Luensdorf, H.; Timmis, K.N.; Golyshin, P.N. 2004: Thalassolituus oleivorans gen. nov., sp. nov., a novel marine bacterium that obligately utilizes hydrocarbons. International Journal of Systematic and Evolutionary Microbiology 54(Pt 1): 141-148

Yi, H.; Bae, K.S.; Chun, J. 2004: Thalassomonas ganghwensis sp. nov., isolated from tidal flat sediment. International Journal of Systematic and Evolutionary Microbiology 54(Part 2): 377-380

Thompson, F.L.; Barash, Y.; Sawabe, T.; Sharon, G.; Swings, J.; Rosenberg, E. 2006: Thalassomonas loyana sp. nov., a causative agent of the white plague-like disease of corals on the Eilat coral reef. International Journal of Systematic and Evolutionary Microbiology 56(Part 2): 365-368

Hand, R. 2004: Thalictrum minus in Bayern - erganzende Anmerkungen und Bestimmungshinweise. Berichte der Bayerischen Botanischen Gesellschaft zur Erforschung der Heimischen Flora 73-7: 57-62

Hand, R. 2004: Thalictrum minus in Brandenburg - Anmerkungen zu Taxonomie, Nomenklatur und Bestimmung der Kleinen Wiesenraute. Verhandlungen des Botanischen Vereins von Berlin und Brandenburg 137: 271-276

Yang, Q.; Zhu, G. 2004: Thalictrum pseudoichangense (Ranunculaceae), a new species from Guizhou, China. Novon 14(4): 510-512

Tosi, P.; Zamagni, E.; Cellini, C.; Cangini, D.; Tacchetti, P.; Tura, S.; Baccarani, M.; Cavo, M. 2004: Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure. European Journal of Haematology 73(2): 98-103

Thadani, N.A.; McNamee, J.P.; Winn, L.M. 2006: Thalidomide alters c-MYB and PIM-1 signaling in K-562 cells. Pharmacological Research 54(2): 91-96

Capitosti, S.M.; Hansen, T.P.; Brown, M.L. 2004: Thalidomide analogues demonstrate dual inhibition of both angiogenesis and prostate cancer. Bioorganic and Medicinal Chemistry 12(2): 327-336

Downs, L.S.; Rogers, L.M.; Yokoyama, Y.; Ramakrishnan, S. 2005: Thalidomide and angiostatin inhibit tumor growth in a murine xenograft model of human cervical cancer. Gynecologic Oncology 98(2): 203-210

Stroud, M. 2005: Thalidomide and cancer cachexia: old problem, new hope?. Gut 54(4): 447-448

Barton, J.C. 2003: Thalidomide and dexamethasone therapy of myeloma in a patient with previously untreated B-chronic lymphocytic leukemia. American Journal of Hematology 74(3): 205-207

Barlogie, B.; Tricot, G.; Anaissie, E.; Shaughnessy, J.; Rasmussen, E.; van Rhee, F.; Fassas, A.; Zangari, M.; Hollmig, K.; Pineda-Roman, M.; Lee, C.; Talamo, G.; Thertulien, R.; Kiwan, E.; Krishna, S.; Fox, M.; Crowley, J. 2006: Thalidomide and hematopoietic-cell transplantation for multiple myeloma. New England Journal of Medicine 354(10): 1021-1030

Kiaei, M.; Petri, S.; Kipiani, K.; Gardian, G.; Choi, D.-K.; Chen, J.; Calingasan, N.Y.; Schafer, P.; Muller, G.W.; Stewart, C.; Hensley, K.; Beal, M.F. 2006: Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 26(9): 2467-2473

Kumar, S.; Rajkumar, S.V. 2006: Thalidomide and lenalidomide in the treatment of multiple myeloma. European Journal of Cancer 42(11): 1612-1622

Hashimoto, Y.ichi; Tanatani, Aya; Nagasawa, Kazuo; Miyachi, Hiroyuki 2004: Thalidomide as a multitarget drug and its application as a template for drug design. Drugs of the Future 29(4): 383-391

Shimazawa, R.; Sano, H.; Tanatani, A.; Miyachi, H.; Hashimoto, Y. 2004: Thalidomide as a nitric oxide synthase inhibitor and its structural development. Chemical and Pharmaceutical Bulletin 52(4): 498-499

Teo, S.K.; Stirling, D.I.; Zeldis, J.B. 2005: Thalidomide as a novel therapeutic agent: new uses for an old product. Drug Discovery Today 10(2): 107-114

Park, S.-J.; Kim, H.-S.; Yang, H.-M.; Park, K.-W.; Youn, S.-W.; Jeon, S.-I.; Kim, D.-H.; Koo, B.-K.; Chae, I.-H.; Choi, D.-J.; Oh, B.-H.; Lee, M.-M.; Park, Y.-B. 2004: Thalidomide as a potent inhibitor of neointimal hyperplasia after balloon injury in rat carotid artery. Arteriosclerosis Thrombosis and Vascular Biology 24(5): 885-891

Tamilarasan, K.P.; Kolluru, G.K.; Rajaram, M.; Indhumathy, M.; Saranya, R.; Chatterjee, S. 2006: Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells. Bmc Cell Biology 7: 17

Anderson, G.ül.üm.; Gries, M.; Kurihara, N.; Honjo, T.; Anderson, J.; Donnenberg, V.; Donnenberg, A.; Ghobrial, I.; Mapara, M.Y.; Stirling, D.; Roodman, D.; Lentzsch, S. 2006: Thalidomide derivative CC-4047 inhibits osteoclast formation by down-regulation of PU.1. Blood 107(8): 3098-3105

Zimmermann, C.; Gutmann, H.; Drewe, J. 2006: Thalidomide does not interact with P-glycoprotein. Cancer ChemoTherapy and Pharmacology 57(5): 599-606

Durupt, F.; Coutet, J.; Salles, B.; Penaud, J.F.; Durupt, S. 2005: Thalidomide en 2005: mise au point et utilisation pratique. Journal de Pharmacie Clinique 24(3): 145-157

Murphy-Poulton, S.F.; Boyle, F.; Gu, X.Q.; Mather, L.E. 2006: Thalidomide enantiomers: determination in biological samples by HPLC and vancomycin-CSP. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 831(1-2): 48-56

Guo, T.L.; Chi, R.P.; Karrow, N.A.; Zhang, L.X.; Pruett, S.B.; Germolec, D.R.; White, K.L. 2005: Thalidomide enhances both primary and secondary host resistances to Listeria monocytogenes infection by a neutrophil-related mechanism in female B6C3F1 mice. Toxicology and Applied Pharmacology 209(3): 244-254

Kim, S.Yeon.; Lee, S.Ah.; Ryoo, H.Mo.; Lee, K.Hee.; Hyun, M.Soo.; Bae, S.Hwa. 2006: Thalidomide for POEMS syndrome. Annals of Hematology 85(8): 545-546

Pro, B.; Younes, A.; Albitar, M.; Dang, N.H.; Samaniego, F.; Romaguera, J.; McLaughlin, P.; Hagemeister, F.B.; Rodriguez, M.A.; Clemons, M.; Cabanillas, F. 2004: Thalidomide for patients with recurrent lymphoma. Cancer 100(6): 1186-1189

Richardson, P.; Schlossman, R.; Jagannath, S.; Alsina, M.; Desikan, R.; Blood, E.; Weller, E.; Mitsiades, C.; Hideshima, T.; Davies, F.; Doss, D.; Freeman, A.; Bosch, J.; Patin, J.; Knight, R.; Zeldis, J.; Dalton, W.; Anderson, K. 2004: Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activity. Mayo Clinic Proceedings 79(7): 875-882

Lehman, T.J.A.; Schechter, S.J.; Sundel, R.P.; Oliveira, S.K.; Huttenlocher, A.; Onel, K.B. 2004: Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study. Journal of Pediatrics 145(6): 856-857

Izzedine, H.; Launay-Vacher, V.; Deray, G. 2005: Thalidomide for the nephrologist. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 20(9): 2011-2012

Strupp, C.; Germing, U.; Scherer, A.; Kündgen, A.; Mödder, U.; Gattermann, N.; Haas, R. 2004: Thalidomide for the treatment of idiopathic myelofibrosis. European Journal of Haematology 72(1): 52-57

Hattori, Y.; Iguchi, T. 2004: Thalidomide for the treatment of multiple myeloma. Congenital Anomalies 44(3): 125-136

Cuadrado, M.J.; Karim, Y.; Sanna, G.; Smith, E.; Khamashta, M.A.; Hughes, G.R.V. 2005: Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens. American Journal of Medicine 118(3): 246-250

Sinisalo, M.; Hietaharju, A.; Sauranen, J.; Wirta, O. 2004: Thalidomide in POEMS syndrome: case report. American Journal of Hematology 76(1): 66-68

Schütt, P.; Ebeling, P.; Buttkereit, U.; Brandhorst, D.; Opalka, B.; Poser, M.; Müller, S.; Flasshove, M.; Moritz, T.; Seeber, S.; Nowrousian, M.R. 2005: Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival. Annals of Hematology 84(9): 594-600

Schütt, P.; Ebeling, P.; Buttkereit, U.; Brandhorst, D.; Opalka, B.; Hoiczyk, M.; Flasshove, M.; Hense, J.; Bojko, P.; Metz, K.; Moritz, T.; Seeber, S.; Nowrousian, M.R. 2005: Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma. European Journal of Haematology 74(1): 40-46

Sleijfer, S.; Kruit, W.H.J.; Stoter, G. 2004: Thalidomide in solid tumours: the resurrection of an old drug. European Journal of Cancer 40(16): 2377-2382

Ozanic Bulic, S.; Fassihi, H.; Mellerio, J.E.; McGrath, J.A.; Atherton, D.J. 2005: Thalidomide in the management of epidermolysis bullosa pruriginosa. British Journal of Dermatology 152(6): 1332-1334

Gordon, J.N.; Trebble, T.M.; Ellis, R.D.; Duncan, H.D.; Johns, T.; Goggin, P.M. 2005: Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial. Gut 54(4): 540-545

Milazzo, L.; Biasin, M.; Gatti, N.; Piacentini, L.; Niero, F.; Zanone Poma, B.; Galli, M.; Moroni, M.; Clerici, M.; Riva, A. 2006: Thalidomide in the treatment of chronic hepatitis C unresponsive to alfa-interferon and ribavirin. American Journal of Gastroenterology 101(2): 399-402

Patt, Y.Z.; Hassan, M.M.; Lozano, R.D.; Nooka, A.K.; Schnirer, I.I.; Zeldis, J.B.; Abbruzzese, J.L.; Brown, T.D. 2005: Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase Ii trial. Cancer 103(4): 749-755

Czyzewski, K.; Zaborowska, A.; Styczyński, J. 2006: Thalidomide increases in vitro sensitivity of childhood acute lymphoblastic leukemia cells to prednisolone and cytarabine. Archivum Immunologiae et Therapiae Experimentalis 54(5): 341-345

Gockel, H.R.; Lügering, A.; Heidemann, J.; Schmidt, M.; Domschke, W.; Kucharzik, T.; Lügering, N. 2004: Thalidomide induces apoptosis in human monocytes by using a cytochrome c-dependent pathway. Journal of Immunology 172(8): 5103-5109

Lu, K.Q.; Brenneman, S.; Burns, R.; Vink, A.; Gaines, E.; Haake, A.; Gaspari, A. 2003: Thalidomide inhibits UVB-induced mouse keratinocyte apoptosis by both TNF-alpha-dependent and TNF-alpha-independent pathways. Photodermatology Photoimmunology and Photomedicine 19(6): 272-280

Du, G.-J.; Lin, H.-H.; Xu, Q.-T.; Wang, M.-W. 2005: Thalidomide inhibits growth of tumors through COX-2 degradation independent of antiangiogenesis. Vascular Pharmacology 43(2): 112-119

Mascarenhas, R.C.V.; Sanghvi, A.N.; Friedlander, L.; Geyer, S.J.; Beasley, H.S.; Van Thiel, D.H. 2004: Thalidomide inhibits the growth and progression of hepatic epithelioid hemangioendothelioma. Oncology 67(5-6): 471-475

Deng, L.; Ding, W.; Granstein, R.D. 2003: Thalidomide inhibits tumor necrosis factor-alpha production and antigen presentation by Langerhans cells. Journal of Investigative Dermatology 121(5): 1060-1065

Kaicker, S.; McCrudden, K.W.; Beck, L.; New, T.; Huang, J.; Frischer, J.S.; Serur, A.; Kadenhe-Chiweshe, A.; Yokoi, A.; Kandel, J.J.; Yamashiro, D.J. 2003: Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma. International Journal of Oncology 23(6): 1651-1655

Morabito, A.; Carillio, G.; Longo, R.; Gasparini, G. 2005: Thalidomide is inactive in heavily pretreated patients with metastatic breast cancer. Cancer Journal 11(3): 248-251

Isoardo, G.; Bergui, M.; Durelli, L.; Barbero, P.; Boccadoro, M.; Bertola, A.; Ciaramitaro, P.; Palumbo, A.; Bergamasco, B.; Cocito, D. 2004: Thalidomide neuropathy: clinical, electrophysiological and neuroradiological features. Acta Neurologica Scandinavica 109(3): 188-193

Briani, C.; Zara, G.; Rondinone, R.; Della Libera, S.; Ermani, M.; Ruggero, S.; Ghirardello, A.; Zampieri, S.; Doria, A. 2004: Thalidomide neurotoxicity: prospective study in patients with lupus erythematosus. Neurology 62(12): 2288-2290

Palumbo, A.; Falco, P.; Ambrosini, M.T.; Petrucci, M.T.; Musto, P.; Caravita, T.; Pregno, P.; Bertola, A.; Cavallo, F.; Ciccone, G.; Boccadoro, M. 2005: Thalidomide plus dexamethasone is an effective salvage regimen for myeloma patients relapsing after autologous transplant. European Journal of Haematology 75(5): 391-395

Epperly, M.W.; Greenberger, E.E.; Franicola, D.; Jacobs, S.; Greenberger, J.S. 2006: Thalidomide radiosensitization of normal murine hematopoietic but not squamous cell carcinoma or multiple myeloma tumor cell lines. In Vivo 20(3): 333-339

Chen, C-Sheng.; Perng, W-Cherng.; Chen, C-Wen.; Huang, K-Lun.; Wu, C-Pyng.; Yen, M-Hsiung. 2004: Thalidomide reduces lipopolysaccharide/zymosan-induced acute lung injury in rats. Journal of Biomedical Science 11(5): 591-598

Kedar, I.; Mermershtain, W.; Ivgi, H. 2004: Thalidomide reduces serum C-reactive protein and interleukin-6 and induces response to IL-2 in a fraction of metastatic renal cell cancer patients who failed IL-2-based therapy. International Journal of Cancer 110(2): 260-265

Mohty, M.; Attal, M.; Marit, G.; Bulabois, C.E.; Garban, F.; Gratecos, N.; Rio, B.; Vernant, J.P.; Sotto, J.J.; Cahn, J.Y.; Blaise, D.; Jouet, J.P.; Facon, T.; Yakoub-Agha, I. 2005: Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myelome (IFM) and the Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC). Bone Marrow Transplantation 35(2): 165-169

Yeh, T-Sen.; Ho, Y-Pin.; Huang, S-Feng.; Yeh, J-Nan.; Jan, Y-Yin.; Chen, M-Fu. 2004: Thalidomide salvages lethal hepatic necroinflammation and accelerates recovery from cirrhosis in rats. Journal of Hepatology 41(4): 606-612

Cavaletti, G.; Beronio, A.; Reni, L.; Ghiglione, E.; Schenone, A.; Briani, C.; Zara, G.; Cocito, D.; Isoardo, G.; Ciaramitaro, P.; Plasmati, R.; Pastorelli, F.; Frigo, M.; Piatti, M.; Carpo, M. 2004: Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study. Neurology 62(12): 2291-2293

Musto, P. 2004: Thalidomide therapy for myelodysplastic syndromes: current status and future perspectives. Leukemia Research 28(4): 325-332

Thomas, D.A.; Giles, F.J.; Albitar, M.; Cortes, J.E.; Verstovsek, S.; Faderl, S.; O'Brien, S.M.; Garcia-Manero, G.; Keating, M.J.; Pierce, S.; Zeldis, J.; Kantarjian, H.M. 2006: Thalidomide therapy for myelofibrosis with myeloid metaplasia. Cancer 106(9): 1974-1984

Invernizzi, R.; Travaglino, E.; De Amici, M.; Brugnatelli, S.; Ramajoli, I.; Rovati, B.; Benatti, C.; Ascari, E. 2005: Thalidomide treatment reduces apoptosis levels in bone marrow cells from patients with myelodysplastic syndromes. Leukemia Research 29(6): 641-647

Abgrall, J-François.; Guibaud, I.; Bastie, J-Noël.; Flesch, M.; Rossi, J-François.; Lacotte-Thierry, L.; Boyer, Fçoise.; Casassus, P.; Slama, B.; Berthou, C.; Rodon, P.; Leporrier, M.; Villemagne, B.; Himberlin, C.; Ghomari, K.; Larosa, F.; Rollot, F.; Dugay, J.; Allard, C.; Maigre, M.; Isnard, Fçoise.; Zerbib, R.; Cauvin, J-Michel. 2006: Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study. Haematologica 91(8): 1027-1032

Duyvendak, M.; Naunton, M.; Kingma, B.J.; Brouwers, J.R.B.J. 2005: Thalidomide-associated thrombocytopenia. Annals of PharmacoTherapy 39(11): 1936-1939

Greig, N.H.; Giordano, T.; Zhu, X.; Yu, Q-sheng.; Perry, T.Ann.; Holloway, H.W.; Brossi, A.; Rogers, J.T.; Sambamurti, K.; Lahiri, D.K. 2004: Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases. Acta Neurobiologiae Experimentalis 64(1): 1-9

Wang, M.; Weber, D.M.; Delasalle, K.; Alexanian, R. 2005: Thalidomide-dexamethasone as primary therapy for advanced multiple myeloma. American Journal of Hematology 79(3): 194-197

Dharia, S.P.; Steinkampf, M.P.; Cater, C. 2004: Thalidomide-induced amenorrhea: case report and literature review. Fertility and Sterility 82(2): 460-462

Yabu, T.; Tomimoto, H.; Taguchi, Y.; Yamaoka, S.; Igarashi, Y.; Okazaki, T. 2005: Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate. Blood 106(1): 125-134

Hattori, Y.; Kakimoto, T.; Okamoto, S.; Sato, N.; Ikeda, Y. 2004: Thalidomide-induced severe neutropenia during treatment of multiple myeloma. International Journal of Hematology 79(3): 283-288

Abdel-Razeq, H., N.; Mousa, S., A. 2004: Thalidomide: a new old drug in the treatment of multiple myeloma. Drugs of the Future 29(10): 1059-1063

Wu, J.J.; Huang, D.B.; Pang, K.R.; Hsu, S.; Tyring, S.K. 2005: Thalidomide: dermatological indications, mechanisms of action and side-effects. British Journal of Dermatology 153(2): 254-273

Chiao, C-Wei.; Lee, S-Sheng.; Wu, C-Chen.; Su, M-Jai. 2005: Thaliporphine increases survival rate and attenuates multiple organ injury in LPS-induced endotoxaemia. Naunyn-Schmiedeberg's Archives of Pharmacology 371(1): 34-43

Hemm, S.; Vayssiere, N.; Zanca, M.; Ravel, P.; Coubes, P. 2004: Thallium SPECT-based stereotactic targeting for brain tumor biopsies. A technical note. Stereotactic and Functional Neurosurgery 82(2-3): 70-76

Lin, T.S.; Chang, C.L. 2005: Thallium in whole blood samples from college students in Taiwan. Bulletin of Environmental Contamination and Toxicology 74(6): 1053-1057

Hanzel, C.E.; Verstraeten, S.V. 2006: Thallium induces hydrogen peroxide generation by impairing mitochondrial function. Toxicology and Applied Pharmacology 216(3): 485-492

Haas, R.L.M.; Valdés-Olmos, R.A.; Hoefnagel, C.A.; Verheij, M.; de Jong, D.; Hart, A.A.M.; Bartelink, H. 2003: Thallium-201-chloride scintigraphy in staging and monitoring radiotherapy response in follicular lymphoma patients. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 69(3): 323-328

Roleda, M.Y.; Wiencke, C.; Hanelt, D. 2006: Thallus morphology and optical characteristics affect growth and DNA damage by UV radiation in juvenile Arctic Laminaria sporophytes. Planta 223(3): 407-417

Yoshizaki, M. 2004: Thallus structure and reproductive organs of Nemalionopsis tortuosa (Rhodophyta). Bulletin of the National Science Museum Series B (Botany) 30(2): 55-62

Mastracci, M. 2004: Thamnobryum rudolphianum (Neckeraceae, Musci), a new species from the Azores. Lindbergia 29(3): 143-147

Pagès, J-Marie.; Dimarcq, J-Luc.; Quenin, S.; Hetru, C. 2003: Thanatin activity on multidrug resistant clinical isolates of Enterobacter aerogenes and Klebsiella pneumoniae. International Journal of Antimicrobial Agents 22(3): 265-269

Bogomolova, I.N.; Bogomolov, D.V. 2005: Thanatogenesis in poisoning with psychic drugs. Sudebno Meditsinskaya Ekspertiza 48(2): 19-22

Prena, J.; Nishida, K. 2005: Thanius biennis, a new gall-inducing weevil with a two-year life-cycle from Costa Rica (Coleoptera: Curculionidae: Baridinae). Beitraege zur Entomologie 55(1): 141-150

Langman, L. 2006: Thank you Felix Geyer. Kybernetes 35(3-4): 317-322

Kao, Y.-S.; Fong, J.C. 2004: Thapsigargin and EGTA inhibit endothelin-1-induced glucose transport. Journal of Biomedical Science 11(2): 206-213

Jin, T.; Nakatani, H.; Taguchi, T.; Sonobe, H.; Morimoto, N.; Sugimoto, T.; Akimori, T.; Nakano, T.; Namikawa, T.; Kabayashi, T.; Kobayashi, M.; Araki, K. 2006: Thapsigargin enhances cell death in the gastrointestinal stromal tumor cell line, GIST-T1, by treatment with imatinib (glivec). Journal of Health Science 52(2): 110-117

Yip, K.H.M.; Zheng, M.H.; Steer, J.H.; Giardina, T.M.; Han, R.; Lo, S.Z.; Bakker, A.J.; Cassady, A.I.; Joyce, D.A.; Xu, J. 2005: Thapsigargin modulates osteoclastogenesis through the regulation of RANKL-induced signaling pathways and reactive oxygen species production. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 20(8): 1462-1471

Huang, L.; Xu, J.; Li, K.; Zheng, M.H.; Kumta, S.-M. 2004: Thapsigargin potentiates TRAIL-induced apoptosis in giant cell tumor of bone. Bone 34(6): 971-981

O'Neill, J.P.; Velalar, C.Natesa.; Lee, D.Ik.; Zhang, B.; Nakanishi, T.; Tang, Y.; Selaru, F.; Ross, D.; Meltzer, S.J.; Hussain, A. 2006: Thapsigargin resistance in human prostate cancer cells. Cancer 107(3): 649-659

Bobbin, R.P.; Parker, M.; Wall, L. 2003: Thapsigargin suppresses cochlear potentials and DPOAEs and is toxic to hair cells. Hearing Research 184(1-2): 51-60

Takadera, T.; Yoshikawa, R.; Ohyashiki, T. 2006: Thapsigargin-induced apoptosis was prevented by glycogen synthase kinase-3 inhibitors in PC12 cells. Neuroscience Letters 408(2): 124-128

Tobin, V.A.; Hurst, G.; Norrie, L.; Dal Rio, F.P.; Bull, P.M.; Ludwig, M. 2004: Thapsigargin-induced mobilization of dendritic dense-cored vesicles in rat supraoptic neurons. European Journal of Neuroscience 19(10): 2909-2912

Cruz-Cruz, R.; Salgado, A.; Sánchez-Soto, C.; Vaca, L.; Hiriart, M. 2005: Thapsigargin-sensitive cationic current leads to membrane depolarization, calcium entry, and insulin secretion in rat pancreatic beta-cells. American Journal of Physiology. Endocrinology and Metabolism 289(3): E439-E445

Lovgren, R.; Dalsved, B. 2005: Thaumetopoea processionea L. ekprocessionsspinnaren, funnen i Sverige. Entomologisk Tidskrift 126(1-2): 93-94

Hansen, E.; Trinderup, R.A.; Hviid, M.; Darre, M.; Skibsted, L.H. 2003: Thaw drip loss and protein characterization of drip from air-frozen, cryogen-frozen, and pressure-shift-frozen pork longissimus dorsi in relation to ice crystal size. European Food Research and Technology 218(1): 2-6

Trudel, G.; Koike, Y.; Dinh, L.; Uhthoff, H.K. 2005: Thawing of frozen calcaneus bone specimens has no effect on the bone mineral density using dual energy x-ray absorptiometry: a study in rabbits and humans. Physiological Measurement 26(5): 769-777

Hoebeeck, J.; Vandesompele, J.; Nilsson, H.én.; De Preter, K.; Van Roy, N.; De Smet, E.; Yigit, N.; De Paepe, A.; Laureys, G.èv.; Påhlman, S.; Speleman, F. 2006: The von Hippel-Lindau tumor suppressor gene expression level has prognostic value in neuroblastoma. International Journal of Cancer 119(3): 624-629

Peruzzi, B.; Athauda, G.; Bottaro, D.P. 2006: The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells. Proceedings of the National Academy of Sciences of the United States of America 103(39): 14531-14536

Snider, D.D.; Clarke, D.; Finucane, B.T. 2004: The "BURP" maneuver worsens the glottic view when applied in combination with cricoid pressure. Canadian Journal of Anaesthesia 52(1): 100-104

Boukhtouche, F.; Mariani, J.; Tedgui, A. 2004: The "CholesteROR" protective pathway in the vascular system. Arteriosclerosis Thrombosis and Vascular Biology 24(4): 637-643

Cristescu, M.E.; Hebert, P.D. 2005: The Crustacean Seas - an evolutionary perspective on the Ponto-Caspian peracarids. Canadian Journal of Fisheries and Aquatic Sciences ch; 62(3): 505-517

Goverman, J.; Yelon, J.A.; Platz, J.Joseph.; Singson, R.C.; Turcinovic, M. 2006: The "Fistula VAC," a technique for management of enterocutaneous fistulae arising within the open abdomen: report of 5 cases. Journal of Trauma 60(2): 428

Cohen, J.C.; Lundblad, L.K.A.; Bates, J.H.T.; Levitzky, M.; Larson, J.E. 2004: The "Goldilocks effect" in cystic fibrosis: identification of a lung phenotype in the cftr knockout and heterozygous mouse. Bmc Genetics 5: 21

Elhaik, E.; Sabath, N.; Graur, D. 2006: The "inverse relationship between evolutionary rate and age of mammalian genes" is an artifact of increased genetic distance with rate of evolution and time of divergence. Molecular Biology and Evolution 23(1): 1-3

Bartram, J.L.; Rigby, A.S.; Baxter, P.S. 2005: The "Lasso-o" tape: stretchability and observer variability in head circumference measurement. Archives of Disease in Childhood 90(8): 820-821

Reischies, F.M.; Wertenauer, F.; Kuehl, K.P. 2005: The Lector - a testing method to determine verbal educational level. Nervenarzt 76(7): 849-850,852-855

Schüz, J.; Petters, C.; Egle, U.Tiber.; Jansen, B.; Kimbel, R.; Letzel, S.; Nix, W.; Schmidt, L.G.; Vollrath, L. 2006: The "Mainzer EMF-Wachhund": results from a watchdog project on self-reported health complaints attributed to exposure to electromagnetic fields. Bioelectromagnetics 27(4): 280-287

Dementyeva, I.I.; Sandrikov, V.A.; Charnaya, M.A.; Morozov, Y.A.; Trekova, N.A.; Eremenko, A.A. 2004: The Novo Seven (rFVIIa) hemostatic in massive hemorrhages in patients operated on the heart and aorta. Anesteziologiya i Reanimatologiya 5: 11-13

Whelan, B.M.; Mcbratney, A.B. 2000: The Null Hypothesis of precision agriculture management. Precision Agriculture 2(3): 265-279

Chan, Tin-Yam 2004: The Plesionika rostricrescentis (Bate, 1888) and P. lophotes Chace, 1985 species groups of Plesionika Bate, 1888, with descriptions of five new species (Crustacea: Decapoda: Pandalidae). Memoires du Museum National d'Histoire Naturelle 191: 293-318

Ronco, C.; Dell'aquila, R.; Rodighiero, M.P.; Di Loreto, P.; Nalesso, F.; Spanò, E.; Parkhill, R.; Amerling, R.; Levin, N. 2006: The ''Ronco'' catheter for continuous flow peritoneal dialysis. International Journal of Artificial Organs 29(1): 101-112

Carmon, M.; Olsha, O.; Schecter, W.P.; Raveh, D.; Reinus, C.; Hershko, D.D.; Beller, U.; Golomb, E. 2006: The "Sentinel Chain": a new concept for prediction of axillary node status in breast cancer patients. Breast Cancer Research and Treatment 97(3): 323-328

Hess, K.C.; Jones, B.H.; Marquez, B.; Chen, Y.; Ord, T.S.; Kamenetsky, M.; Miyamoto, C.; Zippin, J.H.; Kopf, G.S.; Suarez, S.S.; Levin, L.R.; Williams, C.J.; Buck, J.; Moss, S.B. 2005: The "soluble" adenylyl cyclase in sperm mediates multiple signaling events required for fertilization. Developmental Cell 9(2): 249-259

Brorsson, A.-C.; Kjellson, A.; Aronsson, G.ör.; Sethson, I.; Hambraeus, C.; Jonsson, B.-H. 2004: The "two-state folder" MerP forms partially unfolded structures that show temperature dependent hydrogen exchange. Journal of Molecular Biology 340(2): 333-344

Rosse, R.B.; Deutsch, S.I. 2004: The "Yoking" of glutamatergic brain mechanisms involved in controlling brain neuronal excitability and psychosis to brain mechanisms involved in appetite regulation: a new hypothesis on the origin of psychosis. Medical Hypotheses 62(3): 406-412

Aaronson, D.W. 2006: The "black box" warning and allergy drugs. Journal of Allergy and Clinical Immunology 117(1): 40-44

Chalmin, E.; Menu, M.; Pomies, M.-Pierre; Vignaud, C.; Aujoulat, N.; Geneste, J.-Michel 2004: The blazons of the Lascaux Cave. Anthropologie (Paris) 108(5): 571-592

Hornstein, E.; Benvenisty, N. 2004: The "brainy side" of human embryonic stem cells. Journal of Neuroscience Research 76(2): 169-173

Tarasev, M.; Pinto, A.; Kim, D.; Elliott, S.J.; Ballou, D.P. 2006: The "bridging" aspartate 178 in phthalate dioxygenase facilitates interactions between the Rieske center and the iron(II)--mononuclear center. Biochemistry 45(34): 10208-10216

Realdon, N.; Tagliaboschi, A.; Perin, F.; Ragazzi, E. 2005: The bubble point for validation of drug release or simulated absorption tests for ointments. Pharmazie 60(12): 910-916

Green, J.-Jabour; Bradshaw, C., J.A. 2004: The capacity to reason in conservation biology and policy: the southern elephant seal branding controversy. Journal for Nature Conservation 12(1): 25-39

Smyth, M.D.; Tenenbaum, M.J.; Kaufman, C.B.; Kane, A.A. 2006: The "clamshell" craniotomy technique in treating sagittal craniosynostosis in older children. Journal of Neurosurgery 105(4 Suppl): 245-251

Dmitriyeva, O.A.; Gromashyova, O.S. 2004: The control soft applicable to evaluating the potentialities of coitus without perforating the virginal membrane. Sudebno-Meditsinskaya Ekspertiza 47(2): 21-23

Cameron, K.C.; Di, H.J.; Anwar, M.R.; Russell, J.M.; Barnett, J.W. 2003: The critical ESP value: Does it change with land application of dairy factory effluent?. New Zealand Journal of Agricultural Research 46(2): 147-154

Haspel, R.L.; Jarolím, P. 2005: The "cutting" edge: von Willebrand factor-cleaving protease activity in thrombotic microangiopathies. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 32(2): 177-184

Akitake, B.; Anishkin, A.; Sukharev, S.; Sukharev, S. 2005: The "dashpot" mechanism of stretch-dependent gating in MscS. Journal of General Physiology 125(2): 143-154

Dagan, T.; Blekhman, R.; Graur, D. 2006: The "domino theory" of gene death: gradual and mass gene extinction events in three lineages of obligate symbiotic bacterial pathogens. Molecular Biology and Evolution 23(2): 310-316

Offit, K.; Groeger, E.; Turner, S.; Wadsworth, E.A.; Weiser, M.A. 2004: The "duty to warn" a patient's family members about hereditary disease risks. JAMA 292(12): 1469-1473

Nghiem, D.D.; Olson, P.R.; Ormond, D. 2004: The "fatty pancreas allograft": anatomopathologic findings and clinical experience. Transplantation Proceedings 36(4): 1045-1047

Pintar, A.; Pongor, S.án. 2005: The "first in-last out" hypothesis on protein folding revisited. Proteins 60(4): 584-590

Crow, K.D.; Stadler, P.F.; Lynch, V.J.; Amemiya, C.; Wagner, G.ün.P. 2006: The "fish-specific" Hox cluster duplication is coincident with the origin of teleosts. Molecular Biology and Evolution 23(1): 121-136

Schoenau, E. 2005: The "functional muscle-bone unit": a two-step diagnostic algorithm in pediatric bone disease. Pediatric Nephrology 20(3): 356-359

Grechkin, A.N.; Hamberg, M. 2004: The "heterolytic hydroperoxide lyase" is an isomerase producing a short-lived fatty acid hemiacetal. Biochimica et Biophysica Acta 1636(1): 47-58

Drewes, Aørn.Mohr.; Dimcevski, G.; Sami, S.A.K.; Funch-Jensen, P.; Huynh, K.Dinh.; Le Pera, D.; Arendt-Nielsen, L.; Valeriani, M. 2006: The "human visceral homunculus" to pain evoked in the oesophagus, stomach, duodenum and sigmoid colon. Experimental Brain Research 174(3): 443-452

Farina, J.M.; Castilla, J.C.; Ojeda, F.P. 2003: The idiosyncratic effect of a sentinel' species on contaminated rocky intertidal communities. Ecological Applications 13(6): 1533-1552

Mender, D. 2005: The "infallibility" of psychopathology. American Journal of Psychiatry 162(8): 1551-2; Author Reply 1552

Ribeiro, F.M.; Black, S.A.G.; Prado, V.F.; Rylett, R.J.; Ferguson, S.S.G.; Prado, M.A.M. 2006: The "ins" and "outs" of the high-affinity choline transporter CHT1. Journal of Neurochemistry 97(1): 1-12

Pietrzak, M.; Wieczorek, Z.; Wieczorek, J.; Darzynkiewicz, Z. 2006: The "interceptor" properties of chlorophyllin measured within the three-component system: intercalator-DNA-chlorophyllin. Biophysical Chemistry 123(1): 11-19

Handrick, Ré.; Reinhardt, S.; Kimmig, P.; Jendrossek, D. 2004: The "intracellular" poly(3-hydroxybutyrate) (PHB) depolymerase of Rhodospirillum rubrum is a periplasm-located protein with specificity for native PHB and with structural similarity to extracellular PHB depolymerases. Journal of Bacteriology 186(21): 7243-7253

Söderberg, L.; Dyhre, H.; Roth, B.; Björkman, S. 2006: The "inverted cup" -- a novel in vitro release technique for drugs in lipid formulations. Journal of Controlled Release: Official Journal of the Controlled Release Society 113(1): 80-88

Browne, T.; Fox, R.; Funnell, D.C. 2004: The invisible mountains: Using GIS to examine the extent of mountain terrain in South Africa. Mountain Research and Development 24(1): 28-34

Marumo, K.; Saito, M.; Yamagishi, T.; Fujii, K. 2005: The "ligamentization" process in human anterior cruciate ligament reconstruction with autogenous patellar and hamstring tendons: a biochemical study. American Journal of Sports Medicine 33(8): 1166-1173

O'Driscoll, S.W.M.; Lawton, R.L.; Smith, A.M. 2005: The "moving valgus stress test" for medial collateral ligament tears of the elbow. American Journal of Sports Medicine 33(2): 231-239

Pasqualini, R.; Foroni, M.; Salvioli, G.; Mussi, C. 2004: The "nondipper" elderly: a clinical entity or a bias?. Journal of the American Geriatrics Society 52(6): 967-971

Orozco-Levi, M.; Lloreta, J.; Gea, J. 2006: The "oil well analogy" as a comprehensive interpretation of factors leading to muscle injury and wasting. Ultrastructural Pathology 30(4): 247-252

Malmberg, K.J.; Shiffrin, R.M. 2005: The "one-shot" hypothesis for context storage. Journal of Experimental Psychology. Learning Memory and Cognition 31(2): 322-336

Russell, E., B.; Harton, H., C. 2005: The other factors: Using individual and relationship characteristics to predict sexual and emotional jealousy. Current Psychology 24(4): 242-257

Black, J.S. 2005: The "oy" of sex: a medical perspective. Archives of Sexual Behavior 34(1): 24-6 57-61; Author Reply 63-7

Michaelis, H.; Vennemann, L. 2005: The piece-by-piece predation of Eteone longa on Scolelepis squamata (Polychaetes) - traces on the sediment documenting chase, defence and mutilation. Marine Biology (Berlin) 147(3): 719-724

Kagan, V.E.; Tyurina, Y.Y.; Bayir, H.; Chu, C.T.; Kapralov, A.A.; Vlasova, I.I.; Belikova, N.A.; Tyurin, V.A.; Amoscato, A.; Epperly, M.; Greenberger, J.; Dekosky, S.; Shvedova, A.A.; Jiang, J. 2006: The "pro-apoptotic genies" get out of mitochondria: oxidative lipidomics and redox activity of cytochrome c/cardiolipin complexes. Chemico-Biological Interactions 163(1-2): 15-28

Stephenson, V.C.; Heyding, R.A.; Weaver, D.F. 2005: The "promiscuous drug concept" with applications to Alzheimer's disease. Febs Letters 579(6): 1338-1342

Kaplan, M. 2003: The pseudofirmisternal pectoral girdle of anurans. Alytes Paris ober; 21(1-2): 77-99

Mihara, M.; Sugase, S.; Konaka, K.; Sugai, F.; Sato, T.; Yamamoto, Y.; Hirota, S.; Sakai, K.; Sakoda, S. 2005: The "pulvinar sign" in a case of paraneoplastic limbic encephalitis associated with non-Hodgkin's lymphoma. Journal of Neurology Neurosurgery and Psychiatry 76(6): 882-884

Ferenczi, M.A.; Bershitsky, S.Y.; Koubassova, N.; Siththanandan, V.; Helsby, W.I.; Panine, P.; Roessle, M.; Narayanan, T.; Tsaturyan, A.K. 2005: The "roll and lock" mechanism of force generation in muscle. Structure 13(1): 131-141

Harley, E.M.; Carlsen, K.A.; Loftus, G.R. 2004: The "saw-it-all-along" effect: demonstrations of visual hindsight bias. Journal of Experimental Psychology. Learning Memory and Cognition 30(5): 960-968

Viskin, S.; Rosso, R.; Rogowski, O.; Belhassen, B. 2005: The "short-coupled" variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia?. Journal of Cardiovascular Electrophysiology 16(8): 912-916

Seriès, P.; Lorenceau, J.; Frégnac, Y. 2003: The "silent" surround of V1 receptive fields: theory and experiments. Journal of Physiology Paris 97(4-6): 453-474

Hudspeth, M.P.; Holden, K.R.; Crawford, T.O. 2006: The "slurp" test: bedside evaluation of bulbar muscle fatigue. Pediatrics 118(2): E530-E533

Nachtergaele, F. 2005: The soils to be classified in the World Reference Base for Soil Resources. Eurasian Soil Science 38(Suppl 1): S13-S19

Tsuchiya, S.; Sueoka, K.; Matsuda, N.; Tanigaki, R.; Asada, H.; Hashiba, T.; Kato, S.; Yoshimura, Y. 2005: The "spanning protocol": a new DNA extraction method for efficient single-cell genetic diagnosis. Journal of Assisted Reproduction and Genetics 22(11-12): 407-414

Herrmann, K.A.; Michaely, H.J.; Seiderer, J.; Ochsenkuehn, T.; Reiser, M.F.; Schoenberg, S.O. 2006: The "star-sign" in magnetic resonance enteroclysis: a characteristic finding of internal fistulae in Crohn's disease. Scandinavian Journal of Gastroenterology 41(2): 239-241

Dickel, H.; Bruckner, T.M.; Erdmann, S.M.; Fluhr, J.W.; Frosch, P.J.; Grabbe, J.ür.; Löffler, H.; Merk, H.F.; Pirker, C.; Schwanitz, H.J.; Weisshaar, E.; Brasch, J. 2004: The "strip" patch test: results of a multicentre study towards a standardization. Archives of Dermatological Research 296(5): 212-219

Weiner, I. 2003: The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology 169(3-4): 257-297

Lee, I.-M.; Sesso, H.D.; Oguma, Y.; Paffenbarger, R.S. 2004: The "weekend warrior" and risk of mortality. American Journal of Epidemiology 160(7): 636-641

Tranquilli, A.L.; Giannubilo, S.R. 2004: The "weight" of fetal growth restriction in 437 hypertensive pregnancies. Archives of Gynecology and Obstetrics 270(4): 214-216

Chi, J.H.; Sughrue, M.; Kunwar, S.; Lawton, M.T. 2006: The "yo-yo" technique to prevent cerebrospinal fluid rhinorrhea after anterior clinoidectomy for proximal internal carotid artery aneurysms. Neurosurgery 59(1 Suppl. 1): Ons101

Granger, D.A.; Shirtcliff, E.A.; Booth, A.; Kivlighan, K.T.; Schwartz, E.B. 2004: The "trouble" with salivary testosterone. Psychoneuroendocrinology 29(10): 1229-1240

Calvo, C.; Hermida, Rón.C.; Ayala, D.E.; López, Jé.E.; Fernández, Jé.R.; Domínguez, Mía.J.; Mojón, A.; Covelo, M. 2003: The 'ABPM effect' gradually decreases but does not disappear in successive sessions of ambulatory monitoring. Journal of Hypertension 21(12): 2265-2273

Majumdar, A.; Tinsley, D.; O'Dwyer, J.; Doyle, P.T.; Sandler, J.; Benson, P.; Davies, S.J. 2005: The "Chesterfield stent": an aid to the placement of midpalatal implants. British Journal of Oral and Maxillofacial Surgery 43(1): 36-39

Laufer, I.; Pratt, H. 2005: The 'F-complex' and MMN tap different aspects of deviance. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 116(2): 336-352

Nadziejko, C.; Chi Chen, L.; Nádas, A.; Hwang, J.-S. 2004: The 'Fishing License' method for analysing the time course of effects in repeated measurements. Statistics in Medicine 23(9): 1399-1411

Yagcioglu, S.; Ungan, P. 2006: The 'Franssen' illusion for short duration tones is preattentive: a study using mismatch negativity. Brain Research 1106(1): 164-176

Shapiro, S.; Galboiz, Y.; Lahat, N.; Kinarty, A.; Miller, A. 2003: The 'immunological-synapse' at its APC side in relapsing and secondary-progressive multiple sclerosis: modulation by interferon-beta. Journal of Neuroimmunology 144(1-2): 116-124

Vazirinejad, R.; Lilley, J.M.; Ward, C.D. 2003: The 'Impact on Participation and Autonomy': acceptability of the English version in a multiple sclerosis outpatient setting. Multiple Sclerosis 9(6): 612-615

Specht, R.L.; Mccarthy, F.D. 2005: The 'Snake Woman Story' of Hemple Bay, Groote Eylandt: An Enindilyakwa legend of a tsunami in the Gulf of Carpentaria. Proceedings of the Royal Society of Queensland 112: 77-82

Talbert, D.G. 2006: The 'Sutured Skull' and intracranial bleeding in infants. Medical Hypotheses 66(4): 691-694

Lutz, J.T.; Giebler, R.; Peters, J. 2003: The 'TEI-index' is preload dependent and can be measured by transoesophageal echocardiography during mechanical ventilation. European Journal of Anaesthesiology 20(11): 872-877

Day, K. 2004: The 'Te Potaka' storehouse carvings in Auckland Museum. Records of the Auckland Museum 41: 27-35

Dziobek, I.; Fleck, S.; Rogers, K.; Wolf, O.T.; Convit, A. 2006: The 'amygdala theory of autism' revisited: linking structure to behavior. Neuropsychologia 44(10): 1891-1899

Drobniewski, F.A.; Atun, R.; Fedorin, I.; Bikov, A.; Coker, R. 2004: The 'bear trap': the colliding epidemics of tuberculosis and HIV in Russia. International Journal of Std and Aids 15(10): 641-646

Merkus, P.; Ebbens, F.A.; Muller, B.; Fokkens, W.J. 2006: The 'best method' of topical nasal drug delivery: comparison of seven techniques. Rhinology 44(2): 102-107

Bonapart, I.E.; van Domburg, R.; ten Have, S.M.T.H.; de Herder, W.W.; Erdman, R.A.M.; Janssen, J.A.M.J.L.; van der Lely, A.J. 2005: The 'bio-assay' quality of life might be a better marker of disease activity in acromegalic patients than serum total IGF-i concentrations. European Journal of Endocrinology 152(2): 217-224

Laing, P.; Bacon, A.; McCormack, B.; Gregoriadis, G.; Frisch, Bît.; Schuber, F. 2006: The 'co-delivery' approach to liposomal vaccines: application to the development of influenza-A and hepatitis-B vaccine candidates. Journal of Liposome Research 16(3): 229-235

Ulloa, L.; Tracey, K.J. 2005: The "cytokine profile": a code for sepsis. Trends in Molecular Medicine 11(2): 56-63

Sitkovsky, M.V.; Ohta, A. 2005: The 'danger' sensors that STOP the immune response: the A2 adenosine receptors?. Trends in Immunology 26(6): 299-304

Hughes, A.D.; Lorusso, G.D.; Greer, D.L. 2004: The 'double-layer tape prep': an improvement to a standard technique. Journal of Medical Microbiology 53(Part 5): 455

Casper, R.C. 2006: The 'drive for activity' and "restlessness" in anorexia nervosa: potential pathways. Journal of Affective Disorders 92(1): 99-107

Fuglsang, A. 2004: The 'effective number of codons' revisited. Biochemical and Biophysical Research Communications 317(3): 957-964

Zadikoff, C.; Lang, A.E.; Klein, C. 2006: The 'essentials' of essential palatal tremor: a reappraisal of the nosology. Brain: a Journal of Neurology 129(Part 4): 832-840

Butler, R.J. 2005: The 'fabrosaurid' ornithischian dinosaurs of the Upper Elliot Formation (Lower Jurassic) of South Africa and Lesotho. Zoological Journal of the Linnean Society 145(2): 175-218

Mouhat, S.ép.; Mosbah, A.; Visan, V.; Wulff, H.; Delepierre, M.; Darbon, H.é; Grissmer, S.; De Waard, M.; Sabatier, J.-M. 2004: The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels. Biochemical Journal 377(Part 1): 25-36

Carroll, C.B.; Zajicek, J.P. 2004: The 'harlequin' sign in association with multiple sclerosis. Journal of Neurology 251(9): 1145-1146

Vorweg, M.; Monaca, E.; Doehn, M.; Wappler, F. 2006: The 'heparin lock': cause for iatrogenic coagulopathy. European Journal of Anaesthesiology 23(1): 50-53

Basmaji, F.; Martin-Yken, H.él.èn.; Durand, F.; Dagkessamanskaia, A.; Pichereaux, C.; Rossignol, M.; Francois, J. 2006: The 'interactome' of the Knr4/Smi1, a protein implicated in coordinating cell wall synthesis with bud emergence in Saccharomyces cerevisiae. Molecular Genetics and Genomics: Mgg 275(3): 217-230

Kotschy, A.; Farago, J.; Csampai, A.; Smith, D.A. 2004: The 'inverse electron-demand' Diels-Alder reaction in polymer synthesis. Part 5: Preparation and model reactions of some electron-rich bis-dienamines. Tetrahedron 60(15): 3421-3425

Sergant, J.; Crombe, P.; Perdaen, Y. 2006: The 'invisible' hearths: a contribution to the discernment of Mesolithic non-structured surface hearths. Journal of Archaeological Science 33(7): 999-1007

Seyfarth, J.; Garred, P.; Madsen, H.O. 2005: The 'involution' of mannose-binding lectin. Human Molecular Genetics 14(19): 2859-2869

Bringmann, G.; Pfeifer, R.M.; Schreiber, P.; Hartner, K.; Schraut, M.; Breuning, M. 2004: The 'lactone method': enantioselective preparation of novel P,N-biaryl ligands and their use in the synthesis of the biarylic alkaloids, ancistrotanzanine B and ancistroealaine A. Tetrahedron 60(20): 4349-4360

Snodgrass, W.T. 2007: The "learning curve" in hypospadias surgery. Bju International 100(1): 217

Noverr, M.C.; Huffnagle, G.B. 2005: The 'microflora hypothesis' of allergic diseases. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 35(12): 1511-1520

Köse, A.C.; Demirbas, M. 2004: The 'modified prone position': a new approach for treating pre-vesical stones with extracorporeal shock wave lithotripsy. Bju International 93(3): 369-373

Johnson, S.N.; Birch, A.N.E.; Gregory, P.J.; Murray, P.J. 2006: The 'mother knows best' principle: should soil insects be included in the preference-performance debate?. Ecological Entomology 31(4): 395-401

Rauch, F.; Bailey, D.A.; Baxter-Jones, A.; Mirwald, R.; Faulkner, R. 2004: The 'muscle-bone unit' during the pubertal growth spurt. Bone 34(5): 771-775

Leadbeater, Barry, S.C. 2006: The 'mystery' of the flagellar vane in choanoflagellates. Nova Hedwigia (Suppl 130): 213-223

Alban, S. 2005: The 'precautionary principle' as a guide for future drug development. European Journal of Clinical Investigation 35(Suppl 1): 33-44

Fitzhugh, K. 2006: The 'requirement of total evidence' and its role in phylogenetic systematics. Biology and Philosophy 21(3): 309-351

Malys, N.; Carroll, K.; Miyan, J.; Tollervey, D.; McCarthy, J.E.G. 2004: The 'scavenger' m7GpppX pyrophosphatase activity of Dcs1 modulates nutrient-induced responses in yeast. Nucleic Acids Research 32(12): 3590-3600

Talling, J.F.; Spencer, H.J.; Morison, H.R. 2005: The 'shock period': dynamics of phytoplankton during the spring-summer transition of a stratifying English lake. Hydrobiologia 533(January 15): 15-28

Isaac, N., J.B.; Purvis, A. 2004: The 'species problem' and testing macroevolutionary hypotheses. Diversity and Distributions 10(4): 275-281

Watson, D.M. 2003: The 'standardized search': An improved way to conduct bird surveys. Australian Journal of Ecology 28(5): 515-525

Linder, R.; Dew, D.; Sudhoff, H.; Theegarten, D.; Remberger, K.; Pöppl, S.J.; Wagner, M. 2004: The 'subsequent artificial neural network' (SANN) approach might bring more classificatory power to ANN-based DNA microarray analyses. Bioinformatics 20(18): 3544-3552

Suzuki, H.; Saito, R.; Tomita, M. 2004: The 'weighted sum of relative entropy': a new index for synonymous codon usage bias. Gene 335: 19-23

Williams, L.M.; Palmer, D.; Liddell, B.J.; Song, L.; Gordon, E. 2006: The 'when' and 'where' of perceiving signals of threat versus non-threat. Neuroimage 31(1): 458-467

Crunelli, V.; Tóth, T.I.; Cope, D.W.; Blethyn, K.; Hughes, S.W. 2004: The 'window' T-type calcium current in brain dynamics of different behavioural states. Journal of Physiology 562(Pt 1): 121-129

Stöbel-Richter, Y.; Beutel, M.E.; Finck, C.; Brähler, E. 2005: The 'wish to have a child', childlessness and infertility in Germany. Human Reproduction 20(10): 2850-2857

Rodríguez-Peña, J.M.; Pérez-Díaz, R.M.; Alvarez, S.; Bermejo, C.; García, R.úl.; Santiago, C.; Nombela, C.és.; Arroyo, J. 2005: The 'yeast cell wall chip' - a tool to analyse the regulation of cell wall biogenesis in Saccharomyces cerevisiae. Microbiology 151(Part 7): 2241-2249

Georg-Kraemer, J.E.; Caierao, E.; Minella, E.; Barbosa-Neto, J.F.; Cavalli, S.S. 2004: The (1-3,1-4)-beta-glucanases in malting barley: Enzyme survival and genetic and environmental effects. Journal of the Institute of Brewing 110(4): 303-308

Korstanje, A.; van Eeden, S.; Offerhaus, G.J.A.; Sabbe, L.J.M.; den Hartog, G.; Biemond, I.; Lamers, C.B.H.W. 2006: The 13carbon urea breath test for the diagnosis of Helicobacter pylori infection in subjects with atrophic gastritis: evaluation in a primary care setting. Alimentary Pharmacology and Therapeutics 24(4): 643-650

Faraone-Mennella, M.R.; De Maio, A.; Petrella, A.; Romano, M.; Favaloro, P.; Gambacorta, A.; Lama, L.; Nicolaus, B.; Farina, B. 2006: The (ADP-ribosyl)ation reaction in thermophilic bacteria. Research in Microbiology 157(6): 531-537

Xu, H.; Zhao, L-Juan.; Lei, S-Feng.; Li, M-Xin.; Sun, X.; Deng, F-Yan.; Jiang, D-Ke.; Deng, H-Wen. 2005: The (CA)n polymorphism of the TNFR2 gene is associated with peak bone density in Chinese nuclear families. Journal of Human Genetics 50(6): 301-304

Chen, L-Sheng.; Tassone, F.; Sahota, P.; Hagerman, P.J. 2003: The (CGG)n repeat element within the 5' untranslated region of the FMR1 message provides both positive and negative cis effects on in vivo translation of a downstream reporter. Human Molecular Genetics 12(23): 3067-3074

Ripaud, L.; Maillet, L.; Immel-Torterotot, F.; Durand, F.; Cullin, C. 2004: The (URE3) yeast prion results from protein aggregates that differ from amyloid filaments formed in vitro. Journal of Biological Chemistry 279(49): 50962-50968

Bina, R.; Cisarova, I.; Pavlista, M.; Pavlik, I. 2004: The (bis(eta5-cyclopentadienyl)titanium(IV)-bis(L-methionine)) dichloride. Applied Organometallic Chemistry 18(6): 262-263

Zonneveld, K., A.F.; Meier, K.J.S.bastian; Esper, O.; Siggelkow, D.; Wendler, I.; Willems, H. 2005: The (palaeo-) environmental significance of modern calcareous dinoflagellate cysts: a review. Paläontologische Zeitschrift 79(1): 61-77

Moreira, P.I.; Zhu, X.; Lee, H.-G.; Honda, K.; Smith, M.A.; Perry, G. 2006: The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease. Mechanisms of Ageing and Development 127(6): 501-506

Thalmaier, D.; Dambacher, J.; Seiderer, J.; Konrad, A.; Schachinger, V.; Pfennig, S.; Otte, J.-M.; Crispin, A.; Göke, B.; Ochsenkühn, T.; Lohse, P.; Brand, S. 2006: The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease. Alimentary Pharmacology and Therapeutics 24(7): 1105-1115

Parsons, M.J.; D'Souza, U.M.; Arranz, M.-J.; Kerwin, R.W.; Makoff, A.J. 2004: The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity. Biological Psychiatry 56(6): 406-410

Van Goor, M.P.J.; Gómez-García, E.B.; Leebeek, F.W.G.; Brouwers, G.J.; Koudstaal, P.J.; Dippel, D.W.J. 2005: The -148 C/T fibrinogen gene polymorphism and fibrinogen levels in ischaemic stroke: a case-control study. Journal of Neurology Neurosurgery and Psychiatry 76(1): 121-123

Herbert, A.; Liu, C.; Karamohamed, S.; Schiller, J.; Liu, J.; Yang, Q.; Wilson, P.W.F.; Cupples, L.A.; Meigs, J.B. 2005: The -174 IL-6 GG genotype is associated with a reduced risk of type 2 diabetes mellitus in a family sample from the National Heart, Lung and Blood Institute's Framingham Heart Study. Diabetologia 48(8): 1492-1495

Giacconi, R.; Cipriano, C.; Albanese, F.; Boccoli, G.; Saba, V.; Olivieri, F.; Franceschi, C.; Mocchegiani, E. 2004: The -174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing. Experimental Gerontology 39(4): 621-628

Kaikkonen, K.S.; Kakko, S.; Kortelainen, M.L.; Tapanainen, J.M.; Savolainen, M.J.; Antero Kesäniemi, Y.; Huikuri, H.V.; Savolainen, E.R. 2005: The -1C to T polymorphism in the annexin A5 gene is not associated with the risk of acute myocardial infarction or sudden cardiac death in middle-aged Finnish males. Scandinavian Journal of Clinical and Laboratory Investigation 65(2): 133-140

Cipriano, C.; Caruso, C.; Lio, D.; Giacconi, R.; Malavolta, M.; Muti, E.; Gasparini, N.; Franceschi, C.; Mocchegiani, E. 2005: The -308G/A polymorphism of TNF-alpha influences immunological parameters in old subjects affected by infectious diseases. International Journal of Immunogenetics 32(1): 13-18

Salvat, C.; Wang, G.; Dastur, A.; Lyon, N.; Huibregtse, J.M. 2004: The -4 phenylalanine is required for substrate ubiquitination catalyzed by HECT ubiquitin ligases. Journal of Biological Chemistry 279(18): 18935-18943

Hudson, D.E.; Mokone, G.G.; Noakes, T.D.; Collins, M. 2004: The -55 C/T polymorphism within the UCP3 gene and performance during the South African Ironman Triathlon. International Journal of Sports Medicine 25(6): 427-432

Pieters, K.; Pettersson, A.; Gullberg, U.; Hellmark, T. 2004: The - 564 A/G polymorphism in the promoter region of the proteinase 3 gene associated with Wegener's granulomatosis does not increase the promoter activity. Clinical and Experimental Immunology 138(2): 266-270

Pawlik, A.; Wrzesniewska, J.; Florczak, M.; Gawronska-Szklarz, B.; Herczynska, M. 2005: The -590 IL-4 promoter polymorphism in patients with rheumatoid arthritis. Rheumatology International 26(1): 48-51

D'Adamo, M.; Perego, L.; Cardellini, M.; Marini, M.A.; Frontoni, S.; Andreozzi, F.; Sciacqua, A.; Lauro, D.; Sbraccia, P.; Federici, M.; Paganelli, M.; Pontiroli, A.E.; Lauro, R.; Perticone, F.; Folli, F.; Sesti, G. 2004: The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. Diabetes 53(7): 1905-1910

Kiechle, F.L.; Zhang, X.; Holland-Staley, C.A. 2004: The -omics era and its impact. Archives of Pathology and Laboratory Medicine 128(12): 1337-1345

Fuhrmann, C.N.; Kelch, B.A.; Ota, N.; Agard, D.A. 2004: The 0.83 A resolution crystal structure of alpha-lytic protease reveals the detailed structure of the active site and identifies a source of conformational strain. Journal of Molecular Biology 338(5): 999-1013

Barac, Y.D.; Zeevi-Levin, N.; Yaniv, G.; Reiter, I.; Milman, F.; Shilkrut, M.; Coleman, R.; Abassi, Z.; Binah, O. 2005: The 1,4,5-inositol trisphosphate pathway is a key component in Fas-mediated hypertrophy in neonatal rat ventricular myocytes. Cardiovascular Research 68(1): 75-86

Christou, E.A.; Jakobi, J.M.; Critchlow, A.; Fleshner, M.; Enoka, R.M. 2004: The 1- to 2-Hz oscillations in muscle force are exacerbated by stress, especially in older adults. Journal of Applied Physiology 97(1): 225-235

Hui, D.S.; Wong, K.T.; Ko, F.W.; Tam, L.S.; Chan, D.P.; Woo, J.; Sung, J.J.Y. 2005: The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest 128(4): 2247-2261

Wilson, D.K.; Cerna, D.; Chew, E. 2005: The 1.1-angstrom structure of the spindle checkpoint protein Bub3p reveals functional regions. Journal of Biological Chemistry 280(14): 13944-13951

Bhaskar, B.; Poulos, T., L. 2005: The 1.13-angstrom structure of iron-free cytochrome c peroxidase. JBIC Journal of Biological Inorganic Chemistry 10(4): 425-430

Raoult, D.; Audic, S.ép.; Robert, C.; Abergel, C.; Renesto, P.; Ogata, H.; La Scola, B.; Suzan, M.; Claverie, J.-M. 2004: The 1.2-megabase genome sequence of Mimivirus. Science 306(5700): 1344-1350

Duff, A.P.; Cohen, A.E.; Ellis, P.J.; Hilmer, K.; Langley, D.B.; Dooley, D.M.; Freeman, H.C.; Guss, J.Mitchell. 2006: The 1.23 Angstrom structure of Pichia pastoris lysyl oxidase reveals a lysine-lysine cross-link. Acta Crystallographica. Section D Biological Crystallography 62(Pt 9): 1073-1084

Park, H.; Adsit, F.G.; Boyington, J.C. 2005: The 1.4 angstrom crystal structure of the human oxidized low density lipoprotein receptor lox-1. Journal of Biological Chemistry 280(14): 13593-13599

Su, H-Poo.; Garman, S.C.; Allison, T.J.; Fogg, C.; Moss, B.; Garboczi, D.N. 2005: The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodies. Proceedings of the National Academy of Sciences of the United States of America 102(12): 4240-4245

Mueller, P.; Sawaya, M., R.; Pashkov, I.; Chan, S.; Nguyen, C.; Wu, Y.; Perry, L.J.; Eisenberg, D. 2005: The 1.70 ANG X-ray crystal structure of Mycobacterium tuberculosis phosphoglycerate mutase. Acta Crystallographica Section D Biological Crystallography 61(Part 3): 309-315

Förster, A.; Masters, E.I.; Whitby, F.G.; Robinson, H.; Hill, C.P. 2005: The 1.9 A structure of a proteasome-11S activator complex and implications for proteasome-PAN/PA700 interactions. Molecular Cell 18(5): 589-599

Henriksson, L., M.; Bjorkelid, C.; Mowbray, S., L.; Unge, T. 2006: The 1.9 angstrom resolution structure of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase, a potential drug target. Acta Crystallographica Section D Biological Crystallography 62(Part 7): 807-813

Herger, B.E.; Mariani, V.L.; Dennison, K.; Shuker, S.B. 2004: The 10 C-terminal residues of HTLV-I protease are not necessary for enzymatic activity. Biochemical and Biophysical Research Communications 320(4): 1306-1308

Estrada, C.A.; Patel, S.R.; Talente, G.; Kraemer, S. 2005: The 10-minute oral presentation: what should I focus on?. American Journal of the Medical Sciences 329(6): 306-309

Ruiz, T.; Mechin, I.; Bär, Jörg.; Rypniewski, W.; Kopperschläger, G.; Radermacher, M. 2003: The 10.8-A structure of Saccharomyces cerevisiae phosphofructokinase determined by cryoelectron microscopy: localization of the putative fructose 6-phosphate binding sites. Journal of Structural Biology 143(2): 124-134

Saxena, S.; Paraje, G.; Sharan, P.; Karam, G.; Sadana, R. 2006: The 10/90 divide in mental health research: trends over a 10-year period. British Journal of Psychiatry: the Journal of Mental Science 188: 81-82

Hong, S.S.; Szolajska, E.; Schoehn, G.; Franqueville, L.; Myhre, S.; Lindholm, L.; Ruigrok, R.W.H.; Boulanger, P.; Chroboczek, J. 2005: The 100K-chaperone protein from adenovirus serotype 2 (Subgroup C) assists in trimerization and nuclear localization of hexons from subgroups C and B adenoviruses. Journal of Molecular Biology 352(1): 125-138

Brönner, Günter.; Sattler, A.M.; Hinney, A.; Soufi, M.; Geller, F.; Schäfer, H.; Maisch, B.; Hebebrand, J.; Schaefer, J.R. 2005: The 103I variant of the melanocortin 4 receptor is associated with low serum triglyceride levels. Journal of Clinical Endocrinology and Metabolism 91(2): 535-538

Rutherford, K.; Bennion, B.J.; Parson, W.W.; Daggett, V. 2006: The 108M polymorph of human catechol O-methyltransferase is prone to deformation at physiological temperatures. Biochemistry 45(7): 2178-2188

Roscioli, T.; Taylor, P.J.; Bohlken, A.; Donald, J.A.; Masel, J.; Glass, I.A.; Buckley, M.F. 2004: The 10q24-linked split hand/split foot syndrome (SHFM3): narrowing of the critical region and confirmation of the clinical phenotype. American Journal of Medical Genetics. Part a 124a (2): 136-141

Lim, S-K.; Lee, E.J.; Kim, H-Y.; Lee, W. 2004: The 10th and 11th residues of short length N-terminal PTH(1-12) analogue are important for its optimum potency. Journal of Peptide Research: Official Journal of the American Peptide Society 64(1): 25-32

Rebuffat, A.G.; Tam, S.; Nawrocki, A.R.; Baker, M.E.; Frey, B.M.; Frey, F.J.; Odermatt, A. 2004: The 11-ketosteroid 11-ketodexamethasone is a glucocorticoid receptor agonist. Molecular and Cellular Endocrinology 214(1-2): 27-37

Bisaglia, M.; Schievano, E.; Caporale, A.; Peggion, E.; Mammi, S. 2006: The 11-mer repeats of human alpha-synuclein in vesicle interactions and lipid composition discrimination: a cooperative role. Biopolymers 84(3): 310-316

Lee, S.Min.; Park, S.Gyoo.; Park, E.; Lee, J.Yeon.; Jung, G. 2003: The 113th and 117th charged amino acids in the 5th alpha-helix of the HBV core protein are necessary for pgRNA encapsidation. Virus Genes 27(3): 227-235

Gianotti, N.; Galli, L.; Boeri, E.; De Bona, A.; Guffanti, M.; Danise, A.; Salpietro, S.; Lazzarin, A.; Castagna, A. 2006: The 118I reverse transcriptase mutation is the only independent genotypic predictor of virologic failure to a stavudine-containing salvage therapy in HIV-1-infected patients. Journal of Acquired Immune Deficiency Syndromes 41(4): 447-452

Grossfeld, P.D.; Mattina, T.; Lai, Z.; Favier, R.; Jones, K.L.; Cotter, F.; Jones, C. 2004: The 11q terminal deletion disorder: a prospective study of 110 cases. American Journal of Medical Genetics. Part a 129a (1): 51-61

Hightower, L.E. 2005: The 12 most frequently viewed articles of 2004. Cell Stress and Chaperones 10(1): 4-6

Grant, B.F.; Dawson, D.A.; Stinson, F.S.; Chou, S.Patricia.; Dufour, M.C.; Pickering, R.P. 2004: The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug and alcohol dependence 74(3): 223-234

Masood, S.; Djaladat, H.; Kouriefs, C.; Keen, M.; Palmer, J.H. 2004: The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia. Bju International 94(9): 1271-1274

Heinonen, S.; Korhonen, S.; Helisalmi, S.; Koivunen, R.; Tapanainen, J.S.; Laakso, M. 2004: The 121Q allele of the plasma cell membrane glycoprotein 1 gene predisposes to polycystic ovary syndrome. Fertility and Sterility 82(3): 743-745

Shi, J.; Zhang, S.; Tang, M.; Liu, X.; Li, T.; Wang, Y.; Han, H.; Guo, Y.; Hao, Y.; Zheng, K.; Kong, X.; Su, Z.; Tong, Y.; Ma, C. 2004: The 1239G/C polymorphism in exon 5 of BACE1 gene may be associated with sporadic Alzheimer's disease in Chinese Hans. American Journal of Medical Genetics. Part B Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 124b(1): 54-57

Madias, J.E. 2004: The 13th multiuse ECG lead: shouldn't we use it more often, and on the same hard copy or computer screen, as the other 12 leads?. Journal of Electrocardiology 37(4): 285-287

Rousseau, P.; Le Discorde, M.; Mouillot, G.ël.; Marcou, C.él.; Carosella, E.D.; Moreau, P. 2003: The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Human Immunology 64(11): 1005-1010

Satoh, J-Ichi.; Yamamura, T.; Arima, K. 2004: The 14-3-3 protein epsilon isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes. American Journal of Pathology 165(2): 577-592

Satoh, J-ichi.; Onoue, H.; Arima, K.; Yamamura, T. 2005: The 14-3-3 protein forms a molecular complex with heat shock protein Hsp60 and cellular prion protein. Journal of Neuropathology and Experimental Neurology 64(10): 858-868

Colucci, M.; Roccatagliata, L.; Capello, E.; Narciso, E.; Latronico, N.; Tabaton, M.; Mancardi, G.L. 2004: The 14-3-3 protein in multiple sclerosis: a marker of disease severity. Multiple Sclerosis 10(5): 477-481

Efendiev, R.; Chen, Z.; Krmar, R.T.; Uhles, S.; Katz, A.I.; Pedemonte, C.H.; Bertorello, A.M. 2005: The 14-3-3 protein translates the NA+,K+-ATPase {alpha}1-subunit phosphorylation signal into binding and activation of phosphoinositide 3-kinase during endocytosis. Journal of Biological Chemistry 280(16): 16272-16277

Koskinen, H.; Krasnov, A.; Rexroad, C.; Gorodilov, Y.; Afanasyev, S.; Mölsä, H. 2004: The 14-3-3 proteins in the teleost fish rainbow trout (Oncorhynchus mykiss). Journal of Experimental Biology 207(Part 19): 3361-3368

Erdal, M.E.; Yilmaz, M.; Herken, H.; Kocoglu, H.; Bayazit, Y., A. 2003: The 1438G/A polymorphism of the 5-HT2A receptor gene is associated with aura in migraine. Pain Clinic 15(3): 315-319

Levchenko, A.; Montplaisir, J.-Y.; Dubé, M.-P.; Riviere, J.-B.; St-Onge, J.; Turecki, G.; Xiong, L.; Thibodeau, P.; Desautels, A.; Verlaan, D.J.; Rouleau, G.A. 2004: The 14q restless legs syndrome locus in the French Canadian population. Annals of Neurology 55(6): 887-891

Gilbert, H.E.; Asokan, R.; Holers, V.Michael.; Perkins, S.J. 2006: The 15 SCR flexible extracellular domains of human complement receptor type 2 can mediate multiple ligand and antigen interactions. Journal of Molecular Biology 362(5): 1132-1147

Wen-Denggui; Zhang-Jianhui; Zhao-Xiuying; Et-Al 2004: The 15-30 years follow-up for the effect of preoperative radiotherapy on the survival of middle and late-staged esophageal carcinoma. Zhongguo Zhongliu Linchuang 31(21): 1209-1212

Blakeley, M.P.; Kalb, A.J.; Helliwell, J.R.; Myles, D.A.A. 2004: The 15-K neutron structure of saccharide-free concanavalin a. Proceedings of the National Academy of Sciences of the United States of America 101(47): 16405-16410

Giri, S.; Rattan, R.; Singh, A.K.; Singh, I. 2004: The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. Journal of Immunology 173(8): 5196-5208

Shureiqi, I.; Jiang, W.; Zuo, X.; Wu, Y.; Stimmel, J.B.; Leesnitzer, L.M.; Morris, J.S.; Fan, H-Zhen.; Fischer, S.M.; Lippman, S.M. 2003: The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells. Proceedings of the National Academy of Sciences of the United States of America 100(17): 9968-9973

Nakagomi, T.; Kitada, O.; Kuribayashi, K.; Yoshikawa, H.; Ozawa, K.; Ogawa, S.; Matsuyama, T. 2004: The 150-kilodalton oxygen-regulated protein ameliorates lipopolysaccharide-induced acute lung injury in mice. American Journal of Pathology 165(4): 1279-1288

Kastbom, A.; Ahmadi, A.; Söderkvist, P.; Skogh, T. 2005: The 158V polymorphism of Fc gamma receptor type IIIA in early rheumatoid arthritis: increased susceptibility and severity in male patients (the Swedish TIRA project). Rheumatology 44(10): 1294-1298

Livesey, K.J.; Wimhurst, V.L.C.; Carter, K.; Worwood, M.; Cadet, E.; Rochette, J.; Roberts, A.G.; Pointon, J.J.; Merryweather-Clarke, A.T.; Bassett, M.L.; Jouanolle, A-M.; Mosser, A.; David, V.; Poulton, J.; Robson, K.J.H. 2004: The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading. Journal of Medical Genetics 41(1): 6-10

Chao, T-Hsing.; Li, Y-Heng.; Chen, J-Hong.; Wu, H-Lin.; Shi, G-Yueh.; Liu, P-Yen.; Tsai, W-Chuan.; Guo, H-Ran. 2004: The 161TT genotype in the exon 6 of the peroxisome-proliferator-activated receptor gamma gene is associated with premature acute myocardial infarction and increased lipid peroxidation in habitual heavy smokers. Clinical Science 107(5): 461-466

Kanazashi, M.; Gomi, K.; Nagano, T.; Tanabe, T.; Arai, T.; Fukae, M. 2006: The 17-kDa sheath protein in enamel proteins induces cementum regeneration in experimental cavities created in a buccal dehiscence model of dogs. Journal of Periodontal Research 41(3): 193-199

Diaz-Silvestre, H.; Espinosa-Cueto, P.; Sanchez-Gonzalez, A.; Esparza-Ceron, M.A.; Pereira-Suarez, A.L.; Bernal-Fernandez, G.; Espitia, C.; Mancilla, R. 2005: The 19-kDa antigen of Mycobacterium tuberculosis is a major adhesin that binds the mannose receptor of THP-1 monocytic cells and promotes phagocytosis of mycobacteria. Microbial Pathogenesis 39(3): 97-107

Lee, Y.K. 2005: The 1926 General Hospital, Singapore. Annals of the Academy of Medicine Singapore 34(6): 52c-60c

Gaidukov, L.; Rosenblat, M.; Aviram, M.; Tawfik, D.S. 2006: The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux. Journal of Lipid Research 47(11): 2492-2502

Elias, S.G.; Peeters, P.H.M.; Grobbee, D.E.; van Noord, P.A.H. 2005: The 1944-1945 Dutch famine and subsequent overall cancer incidence. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 14(8): 1981-1985

Monteleone, P.; Zanardini, R.; Tortorella, A.; Gennarelli, M.; Castaldo, E.; Canestrelli, B.; Maj, M. 2006: The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorder. Neuroscience Letters 406(1-2): 133-137

Carstens, K.C. 2004: The 1974-1975 archaeological excavations at Owl Cave (15Ed43), Mammoth Cave National Park, Kentucky. Journal of the Kentucky Academy of Science 65(1): 12-20

Zienius, D.; Petkevicius, S.; Vysniauskas, A. 2005: The 1995-2000 ORV program in Lithuania wildlife. Medycyna Weterynaryjna 61(10): 1131-1134

Booth, C., K.; Coad, R., A. 2004: The 1998 army recruit health and diet survey. Revue Internationale des Services de Sante des Forces Armees 77(2): 100-102, 104-107

Pearce, J.; Balcom, N. 2005: The 1999 Long Island Sound Lobster mortality event: Findings of the Comprehensive Research Initiative. Journal of Shellfish Research 24(3): 691-697

Mullan, P., B.; Hosey, A., M.; Buckley, N., E.; Quinn, J., E.; Kennedy, R., D.; Johnston, P., G.; Harkin, D.P.ul 2005: The 2,5 oligoadenylate synthetase/RNaseL pathway is a novel effector of BRCA1-and interferon-gamma-mediated apoptosis. Oncogene 24(35): 5492-5501

Smid, L.M.; Vovko, T.D.; Popovic, M.; Petric, A.; Kepe, V.; Barrio, J.R.; Vidmar, G.; Bresjanac, M. 2006: The 2,6-disubstituted naphthalene derivative FDDNP labeling reliably predicts Congo red birefringence of protein deposits in brain sections of selected human neurodegenerative diseases. Brain Pathology 16(2): 124-130

Koehntop, K.D.; Emerson, J.P.; Que, L. 2005: The 2-His-1-carboxylate facial triad: a versatile platform for dioxygen activation by mononuclear non-heme iron(II) enzymes. Journal of Biological Inorganic Chemistry: Jbic: a Publication of the Society of Biological Inorganic Chemistry 10(2): 87-93

Di Stasio, Bît.; Frochot, Céline.; Dumas, D.; Even, P.; Zwier, J.; Müller, A.; Didelon, J.; Guillemin, Fçois.; Viriot, M-Laure.; Barberi-Heyob, M. 2005: The 2-aminoglucosamide motif improves cellular uptake and photodynamic activity of tetraphenylporphyrin. European Journal of Medicinal Chemistry 40(11): 1111-1122

Pérez, S.; Aspichueta, P.; Ochoa, B.ña.; Chico, Y. 2006: The 2-series prostaglandins suppress VLDL secretion in an inflammatory condition-dependent manner in primary rat hepatocytes. Biochimica et Biophysica Acta 1761(2): 160-171

Shukla, A.R.; Patel, R.P.; Canning, D.A. 2004: The 2-stage hypospadias repair. Is it a misnomer?. Journal of Urology 172(4 Pt 2): 1714-6; Discussion 1716

Boks, M.P.M.; Selten, J.-P.; Leask, S.; Van den Bosch, R.J. 2006: The 2-year stability of neurological soft signs after a first episode of non-affective psychosis. European Psychiatry: the Journal of the Association of European Psychiatrists 21(5): 288-290

Gupta, K.; Selinsky, B.S.; Kaub, C.J.; Katz, A.K.; Loll, P.J. 2004: The 2.0 ANG resolution crystal structure of prostaglandin H2 synthase-1: Structural insights into an unusual peroxidase. Journal of Molecular Biology 335(2): 503-518, 9 January

Benach, J.; Edstrom, W., C.; Lee, I.; Das, K.; Cooper, B.; Xiao, R.; Liu, J.; Rost, B.; Acton, T., B.; Montelione, G., T.; Hunt, J., F. 2005: The 2.35 angstrom structure of the TenA homolog from Pyrococcus furiosus supports an enzymatic function in thiamine metabolism. Acta Crystallographica Section D Biological Crystallography 61: 589-598

Garriga, Dà.; Querol-Audí, J.; Abaitua, F.; Saugar, I.; Pous, J.; Verdaguer, Núria.; Castón, Jé.R.; Rodriguez, Jé.F. 2006: The 2.6-Angstrom structure of infectious bursal disease virus-derived T=1 particles reveals new stabilizing elements of the virus capsid. Journal of Virology 80(14): 6895-6905

Tang, Y.; Kim, C-Young.; Mathews, I.I.; Cane, D.E.; Khosla, C. 2006: The 2.7-Angstrom crystal structure of a 194-kDa homodimeric fragment of the 6-deoxyerythronolide B synthase. Proceedings of the National Academy of Sciences of the United States of America 103(30): 11124-11129

Irimia, A.; Vellieux, F.M.D.; Madern, D.; Zaccai, G.; Karshikoff, A.; Tibbelin, G.; Ladenstein, R.; Lien, T.; Birkeland, N.K.re 2004: The 2.9 ANG resolution crystal structure of malate dehydrogenase from Archaeoglobus fulgidus: Mechanisms of oligomerisation and thermal stabilisation. Journal of Molecular Biology 335(1): 343-356, 2 January

Hesseling, P.; Broadhead, R.; Mansvelt, E.; Louw, M.; Wessels, G.; Borgstein, E.; Schneider, J.; Molyneux, E. 2005: The 2000 Burkitt lymphoma trial in Malawi. Pediatric Blood and Cancer 44(3): 245-250

Collia, D.V.; Sharp, J.; Giesbrecht, L. 2003: The 2001 National Household Travel Survey: a look into the travel patterns of older Americans. Journal of Safety Research 34(4): 461-470

Chun, F.K-H.; Briganti, A.; Lebeau, T.; Fradet, V.; Steuber, T.; Walz, J.; Schlomm, T.; Eichelberg, C.; Haese, A.; Erbersdobler, A.; McCormack, M.; Perrotte, P.; Graefen, M.; Huland, H.; Karakiewicz, P.I. 2006: The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy. European Urology 49(2): 273-8; Discussion 278-9

Johnson, E.F. 2003: The 2002 Bernard B. Brodie Award lecture: deciphering substrate recognition by drug-metabolizing cytochromes P450. Drug Metabolism and Disposition: the Biological Fate of Chemicals 31(12): 1532-1540

Zimmerman, R.Kent.; Tabbarah, M.; Bardenheier, B.; Janosky, J.E.; Troy, J.A.; Raymund, M.; Yawn, B.P. 2005: The 2002 United States varicella vaccine shortage and physician recommendations for vaccination. Preventive Medicine 41(2): 575-582

Lillibridge, K.M.; Parsons, R.; Randle, Y.; Travassos da Rosa, A.P.A.; Guzman, H.; Siirin, M.; Wuithiranyagool, T.; Hailey, C.; Higgs, S.; Bala, A.A.; Pascua, R.; Meyer, T.; Vanlandingham, D.L.; Tesh, R.B. 2004: The 2002 introduction of West Nile virus into Harris County, Texas, an area historically endemic for St. Louis encephalitis. American Journal of Tropical Medicine and Hygiene 70(6): 676-681

Inamoto, M. 2005: The 2002 reform of the EC Common Fisheries Policy and multilevel governance. Journal of the Tokyo University of Marine Science and Technology 1: 73-85

Bittman, R. 2004: The 2003 ASBMB-Avanti Award in Lipids Address: Applications of novel synthetic lipids to biological problems. Chemistry and physics of lipids 129(2): 111-131

Burrell, A. 2004: The 2003 CAP reform - Implications for the EU dairy sector. Outlook on Agriculture 33(1): 15-25

Vallar, G. 2004: The 2003 status of cognitive neuropsychology. Cognitive Neuropsychology 21(1): 45-49

Gerlovich, J.; Parsa, R.; Jordan, L. 2004: The 2003 status of science safety in Tennessee secondary schools. Journal of the Tennessee Academy of Science 79(4): 83-90

Armstrong, P.W.; Bogaty, P.; Buller, C.E.; Dorian, P.; O'Neill, B.J. 2004: The 2004 ACC/AHA Guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society Working Group. Canadian Journal of Cardiology 20(11): 1075-1079

McIntosh, T.J. 2004: The 2004 Biophysical Society-Avanti Award in Lipids address: roles of bilayer structure and elastic properties in peptide localization in membranes. Chemistry and physics of lipids 130(2): 83-98

Ragni, G.; Allegra, A.; Anserini, P.; Causio, F.; Ferraretti, A.P.; Greco, E.; Palermo, R.; Somigliana, E. 2005: The 2004 Italian legislation regulating assisted reproduction technology: a multicentre survey on the results of IVF cycles. Human Reproduction 20(8): 2224-2228

Kovacs, K. 2005: The 2004 WHO classification of pituitary tumors: comments. Acta Neuropathologica 111(1): 62-63

Al-Shraim, M.; Asa, S.L. 2006: The 2004 World Health Organization classification of pituitary tumors: what is new?. Acta Neuropathologica 111(1): 1-7

Grossman, A.B. 2005: The 2004 World Health Organization classification of pituitary tumors: is it clinically helpful?. Acta Neuropathologica 111(1): 76-77

Khan, N.A.; McAlister, F.A.; Lewanczuk, R.Z.; Touyz, R.M.; Padwal, R.; Rabkin, S.W.; Leiter, L.A.; Lebel, M.; Herbert, C.; Schiffrin, E.L.; Herman, R.J.; Hamet, P.; Fodor, G.; Carruthers, G.; Culleton, B.; DeChamplain, J.; Pylypchuk, G.; Logan, A.G.; Gledhill, N.; Petrella, R.; Campbell, N.R.C.; Arnold, M.; Moe, G.; Hill, M.D.; Jones, C.; Larochelle, P.; Ogilvie, R.I.; Tobe, S.; Houlden, R.; Burgess, E.; Feldman, R.D. 2005: The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. Canadian Journal of Cardiology 21(8): 657-672

Lyerla, R.; Gouws, E.; García-Calleja, J.M.; Zaniewski, E. 2006: The 2005 Workbook: an improved tool for estimating HIV prevalence in countries with low level and concentrated epidemics. Sexually Transmitted Infections 82 Suppl. 3: Iii41-Iii44

Van den Berg, M.; Birnbaum, L.S.; Denison, M.; De Vito, M.; Farland, W.; Feeley, M.; Fiedler, H.; Hakansson, H.; Hanberg, A.; Haws, L.; Rose, M.; Safe, S.; Schrenk, D.; Tohyama, C.; Tritscher, A.; Tuomisto, J.; Tysklind, M.; Walker, N.; Peterson, R.E. 2006: The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicological Sciences: An Official Journal of the Society of Toxicology 93(2): 223-241

Yukawa, M.; Tsudzuki, T.; Sugiura, M. 2005: The 2005 version of the chloroplast DNA sequence from tobacco (Nicotiana tabacum). Plant Molecular Biology Reporter 23(4): 359-365

Khan, N.A.; McAlister, F.A.; Rabkin, S.W.; Padwal, R.; Feldman, R.D.; Campbell, N.Rc.; Leiter, L.A.; Lewanczuk, R.Z.; Schiffrin, E.L.; Hill, M.D.; Arnold, M.; Moe, G.; Campbell, T.S.; Herbert, C.; Milot, A.; Stone, J.A.; Burgess, E.; Hemmelgarn, B.; Jones, C.; Larochelle, P.; Ogilvie, R.I.; Houlden, R.; Herman, R.J.; Hamet, P.; Fodor, G.; Carruthers, G.; Culleton, B.; Dechamplain, J.; Pylypchuk, G.; Logan, A.G.; Gledhill, N.; Petrella, R.; Tobe, S.; Touyz, R.M. 2006: The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. Canadian Journal of Cardiology 22(7): 583-593

Seydoux, G.; Ambros, V. 2006: The 2006 Genetics Society of America Medal. Victor Ambros. Genetics 172(2): 721-722

Hopper, A.; Sherman, F. 2006: The 2006 George W. Beadle Medal. Fred Sherman. Genetics 172(2): 723-724

Jeang, Kuan-Teh 2006: The 2006 Retrovirology Prize: call for nominations. Retrovirology : 3

Weir, B.; Nei, M. 2006: The 2006 Thomas Hunt Morgan Medal. Masatoshi Nei. Genetics 172(2): 719-720

Balmford, A.; Crane, P.; Dobson, A.; Green, R.E.; Mace, G.M. 2005: The 2010 challenge: data availability, information needs and extraterrestrial insights. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 360(1454): 221-228

Moorthy, A., K.; Savinova, O., V.; Ho, J., Q.; Wang, V.-Ya-Fan; Vu, D.; Ghosh, G. 2006: The 20S proteasome processes NF-kappa B1 p105 into p50 in a translation-independent manner. EMBO (European Molecular Biology Organization) Journal 25(9): 1945-1956

Taherzadeh, M.; Fradette, C.; Bleau, A-Marie.; Jomphe, C.; Trudeau, L-Eric.; du Souich, P. 2006: The 21-aminosteroid U74389G prevents the down-regulation and decrease in activity of CYP1A1, 1A2 and 3A6 induced by an inflammatory reaction. Biochemical Pharmacology 71(3): 366-376

Vorstman, J.A.S.; Morcus, M.E.J.; Duijff, S.N.; Klaassen, P.W.J.; Heineman-de Boer, J.A.; Beemer, F.A.; Swaab, H.; Kahn, Ré.S.; van Engeland, H. 2006: The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. Journal of the American Academy of Child and Adolescent Psychiatry 45(9): 1104-1113

Melegaro, A.; Edmunds, W.John. 2004: The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses. European Journal of Epidemiology 19(4): 353-363

Melegaro, A.; Edmunds, W.John. 2004: The 23-valent pneumococcal polysaccharide vaccine. Part II. A cost-effectiveness analysis for invasive disease in the elderly in England and Wales. European Journal of Epidemiology 19(4): 365-375

Alders, M.; Jongbloed, R.; Deelen, W.; van den Wijngaard, A.; Doevendans, P.; Ten Cate, F.; Regitz-Zagrosek, V.; Vosberg, H.Peter.; van Langen, I.; Wilde, A.; Dooijes, D.; Mannens, M. 2003: The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. European Heart Journal 24(20): 1848-1853

Kim, T.Jung.; Lee, J.Il. 2006: The 23S rRNA gene PCR-RFLP used for characterization of porcine intestinal spirochete isolates. Journal of Veterinary Science 7(3): 277-280

Rouveix, M.; Duclos, M.; Gouarne, C.; Beauvieux, M.C.; Filaire, E. 2006: The 24 h urinary cortisol/cortisone ratio and epinephrine/norepinephrine ratio for monitoring training in young female tennis players. International Journal of Sports Medicine 27(11): 856-863

van Haarst, E.P.; Heldeweg, E.A.; Newling, D.W.; Schlatmann, T.J. 2004: The 24-h frequency-volume chart in adults reporting no voiding complaints: defining reference values and analysing variables. Bju International 93(9): 1257-1261

Brandenberger, G.; Weibel, L. 2004: The 24-h growth hormone rhythm in men: sleep and circadian influences questioned. Journal of Sleep Research 13(3): 251-255

Atlaoui, D.; Duclos, M.; Gouarne, C.; Lacoste, L.; Barale, F.; Chatard, J.-C. 2004: The 24-h urinary cortisol/cortisone ratio for monitoring training in elite swimmers. Medicine and Science in Sports and Exercise 36(2): 218-224

Prins, G., S.; Bremner, W. 2004: The 25th volume: President's message: Andrology in the 20th century: A commentary on our progress during the past 25 years. Journal of Andrology 25(4): 435-440

Xu, W.; Dunn, C.A.; Jones, C.R.; D'Souza, G.; Bessman, M.J. 2004: The 26 Nudix hydrolases of Bacillus cereus, a close relative of Bacillus anthracis. Journal of Biological Chemistry 279(23): 24861-24865

Ushakova, A.V.; Duarte, M.; Vinogradov, A.D.; Videira, A. 2005: The 29.9 kDa subunit of mitochondrial complex I is involved in the enzyme active/de-active transitions. Journal of Molecular Biology 351(2): 327-333

Biron, Z.; Khare, S.; Quadt, S.R.; Hayek, Y.; Naider, F.; Anglister, J. 2005: The 2F5 epitope is helical in the HIV-1 entry inhibitor T-20. Biochemistry 44(41): 13602-13611

Tower, G.B.; Coon, C.I.; Brinckerhoff, C.E. 2003: The 2G single nucleotide polymorphism (SNP) in the MMP-1 promoter contributes to high levels of MMP-1 transcription in MCF-7/ADR breast cancer cells. Breast Cancer Research and Treatment 82(2): 75-82

Patel, A.J.; Lazdunski, M. 2004: The 2P-domain K+ channels: role in apoptosis and tumorigenesis. Pflugers Archiv: European Journal of Physiology 448(3): 261-273

Hokamp, K.; McLysaght, A.; Wolfe, K.H. 2003: The 2R hypothesis and the human genome sequence. Journal of Structural and Functional Genomics 3(1-4): 95-110

Friedberg, E., C.; Hanaoka, F.; Tanaka, K.; Yasui, A.; Wilson, S., H. 2004: The 2nd US-Japan DNA Repair Meeting, Honolulu, Hawaii, June 4-8, 2004. DNA Repair 3(12): 1661-1674

Parvari, R.; Gonen, Y.; Alshafee, I.; Buriakovsky, S.; Regev, K.; Hershkovitz, E. 2005: The 2p21 deletion syndrome: characterization of the transcription content. Genomics 86(2): 195-211

Wang, Z.; Xiang, L.; Shao, J.; Yuan, Z. 2006: The 3' CCACCA sequence of tRNAAla(UGC) is the motif that is important in inducing Th1-like immune response, and this motif can be recognized by Toll-like receptor 3. Clinical and vaccine immunology: CVI 13(7): 733-739

Dunnick, W.A.; Shi, J.; Graves, K.A.; Collins, J.T. 2005: The 3' end of the heavy chain constant region locus enhances germline transcription and switch recombination of the four gamma genes. Journal of Experimental Medicine 201(9): 1459-1466

Hagège, H.; Nasser, R.; Weber, M.; Milligan, L.; Aptel, N.; Jacquet, C.; Drewell, R.A.; Dandolo, L.; Surani, M.A.; Cathala, G.; Forné, T. 2006: The 3' portion of the mouse H19 Imprinting-Control Region is required for proper tissue-specific expression of the Igf2 gene. Cytogenetic and Genome Research 113(1-4): 230-237

Karaer, S.; Sarikaya, A.-Topal; Arda, N.; Temizkan, G. 2006: The 3 ' terminal sequence of the inosine monophosphate dehydrogenase gene encodes an active domain in the yeast Schizosaccharomyces pombe. Genetics and Molecular Biology 29(3): 551-557

Goodarzi, M.O.; Wong, H.; Quiñones, M.J.; Taylor, K.D.; Guo, X.; Castellani, L.W.; Antoine, H.J.; Yang, H.; Hsueh, W.A.; Rotter, J.I. 2005: The 3' untranslated region of the lipoprotein lipase gene: haplotype structure and association with post-heparin plasma lipase activity. Journal of Clinical Endocrinology and Metabolism 90(8): 4816-4823

Gritsun, T.S.; Gould, E.A. 2006: The 3' untranslated regions of Kamiti River virus and Cell fusing agent virus originated by self-duplication. Journal of General Virology 87(Pt 9): 2615-2619

Goebel, S.J.; Taylor, J.; Masters, P.S. 2004: The 3' cis-acting genomic replication element of the severe acute respiratory syndrome coronavirus can function in the murine coronavirus genome. Journal of Virology 78(14): 7846-7851

Dubertret, C.; Gouya, L.; Hanoun, N.; Deybach, J-Charles.; Adès, J.; Hamon, M.; Gorwood, P. 2004: The 3' region of the DRD2 gene is involved in genetic susceptibility to schizophrenia. Schizophrenia Research 67(1): 75-85

Manjithaya, R.R.; Dighe, R.R. 2004: The 3' untranslated region of bovine follicle-stimulating hormone beta messenger RNA downregulates reporter expression: involvement of AU-rich elements and transfactors. Biology of Reproduction 71(4): 1158-1166

Dean, J., L.E.; Wait, R.; Mahtani, K., R.; Sully, G.; Clark, A., R.; Saklatvala, J. 2005: The 3' untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR (vol 21, pg 721, 2001). Molecular and Cellular Biology 25(8): 3400

Golden, D.E.; Hajduk, S.L. 2005: The 3'-untranslated region of cytochrome oxidase II mRNA functions in RNA editing of African trypanosomes exclusively as a cis guide RNA. Rna 11(1): 29-37

Subramaniam, K.; Chen, K.; Joseph, K.; Raymond, J.R.; Tholanikunnel, B.G. 2004: The 3'-untranslated region of the beta2-adrenergic receptor mRNA regulates receptor synthesis. Journal of Biological Chemistry 279(26): 27108-27115

Cai, Y-Jun.; Wei, Q-Yi.; Fang, J-Guo.; Yang, L.; Liu, Z-Li.; Wyche, J.H.; Han, Z. 2004: The 3,4-dihydroxyl groups are important for trans-resveratrol analogs to exhibit enhanced antioxidant and apoptotic activities. Anticancer Research 24(2b): 999-1002

Warburton, N.; Wood, C.; Lloyd, C.; Song, S.; Withers, P. 2003: The 3-dimensional anatomy of the north-western marsupial mole (Notoryctes caurinus Thomas 1920) using computed tomography, X-ray and magnetic resonance imaging. Records of the Western Australian Museum 22(1): 1-7

Lee, A., K.Y.; Chan, C., K.; Fang, M.; Lau, A., P.S. 2004: The 3-hydroxy fatty acids as biomarkers for quantification and characterization of endotoxins and Gram-negative bacteria in atmospheric aerosols in Hong Kong. Atmospheric Environment 38(37): 6307-6317

Malewicz, B.; Valiyaveettil, J.T.; Jacob, K.; Byun, H.-S.; Mattjus, P.; Baumann, W.J.; Bittman, R.; Brown, R.E. 2005: The 3-hydroxy group and 4,5-trans double bond of sphingomyelin are essential for modulation of galactosylceramide transmembrane asymmetry. Biophysical Journal 88(4): 2670-2680

Pooler, A.M.; Xi, S.C.; Wurtman, R.J. 2006: The 3-hydroxy-3-methylglutaryl co-enzyme A reductase inhibitor pravastatin enhances neurite outgrowth in hippocampal neurons. Journal of Neurochemistry 97(3): 716-723

Choi, O-Sun.; Park, S-Joo.; Seo, S-Wan.; Park, C-Seog.; Cho, J-Je.; Ahn, H-Jong. 2005: The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, lovastatin (statin) ameliorates CCK-induced acute pancreatitis in rats. Biological and Pharmaceutical Bulletin 28(8): 1394-1397

Parry, C.D.; Plüddemann, A.; Louw, A.; Leggett, T. 2004: The 3-metros study of drugs and crime in South Africa: findings and policy implications. American Journal of Drug and Alcohol Abuse 30(1): 167-185

Chenven, E.S.; McGinnis, D.; Strup, S.E. 2004: The 3-port laparoscopic pyeloplasty. Journal of Urology 171(3): 1050-1053

Spirig, U.; Bodmer, D.; Wacker, M.; Burda, P.; Aebi, M. 2005: The 3.4-kDa Ost4 protein is required for the assembly of two distinct oligosaccharyltransferase complexes in yeast. Glycobiology 15(12): 1396-1406

Moholkar, K.; McCoy, G. 2004: The 30 ml cement test. Archives of Orthopaedic and Trauma Surgery 124(6): 429

Huzarski, T.; Lener, M.; Domagała, W.; Gronwald, J.; Byrski, T.; Kurzawski, G.; Suchy, J.; Chosia, M.; Woyton, J.; Ucinski, M.ł; Narod, S.A.; Lubiński, J. 2005: The 3020insC allele of NOD2 predisposes to early-onset breast cancer. Breast Cancer Research and Treatment 89(1): 91-93

Folwaczny, M.; Glas, J.ür.; Török, H.-P.; Mauermann, D.; Folwaczny, C. 2004: The 3020insC mutation of the NOD2/CARD15 gene in patients with periodontal disease. European Journal of Oral Sciences 112(4): 316-319

Noller, H.F.; Hoang, L.; Fredrick, K. 2005: The 30S ribosomal P site: a function of 16S rRNA. Febs Letters 579(4): 855-858

Cole, L., W.; Sterling, J., C.; Sterling, J., C. 2006: The 30th report of the California Bird Records Committee: 2004 records. Western Birds 37(2): 65-105

Kim, W.; Kook, S.; Kim, D.J.; Teodorof, C.; Song, W.K. 2004: The 31-kDa caspase-generated cleavage product of p130cas functions as a transcriptional repressor of E2A in apoptotic cells. Journal of Biological Chemistry 279(9): 8333-8342

Mishima, K.; Tozawa, T.; Satoh, K.; Saitoh, H.; Mishima, Y. 2005: The 3111T/C polymorphism of hClock is associated with evening preference and delayed sleep timing in a Japanese population sample. American Journal of Medical Genetics. Part B Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 133b(1): 101-104

Razin, S.V.; Rynditch, A.; Borunova, V.; Ioudinkova, E.; Smalko, V.; Scherrer, K. 2004: The 33 kb transcript of the chicken alpha-globin gene domain is part of the nuclear matrix. Journal of Cellular Biochemistry 92(3): 445-457

Yu, W.-P.; Tan, J.M.M.; Chew, K.C.M.; Oh, T.; Kolatkar, P.; Venkatesh, B.; Dawson, T.M.; Leong Lim, K. 2005: The 350-fold compacted Fugu parkin gene is structurally and functionally similar to human Parkin. Gene 346: 97-104

Lucotte, G.ér.; Diéterlen, F. 2005: The 35delG mutation in the connexin 26 gene (GJB2) associated with congenital deafness: European carrier frequencies and evidence for its origin in ancient Greece. Genetic Testing 9(1): 20-25

Gauczynski, S.; Nikles, D.; El-Gogo, S.; Papy-Garcia, D.; Rey, C.; Alban, S.; Barritault, D.; Lasmezas, C.I.; Weiss, S. 2006: The 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes. Journal of Infectious Diseases 194(5): 702-709

Akache, B.; Grimm, D.; Pandey, K.; Yant, S.R.; Xu, H.; Kay, M.A. 2006: The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. Journal of Virology 80(19): 9831-9836

Lewis, D.A.; McDonald, A.; Thompson, G.; Bingham, J.S. 2004: The 374 clinic: an outreach sexual health clinic for young men. Sexually Transmitted Infections 80(6): 480-483

Thompson, M.J.; Sievers, S.A.; Karanicolas, J.; Ivanova, M.I.; Baker, D.; Eisenberg, D. 2006: The 3D profile method for identifying fibril-forming segments of proteins. Proceedings of the National Academy of Sciences of the United States of America 103(11): 4074-4078

Raspanti, M.; Manelli, A.; Franchi, M.; Ruggeri, A. 2005: The 3D structure of crimps in the rat Achilles tendon. Matrix Biology: Journal of the International Society for Matrix Biology 24(7): 503-507

Harel, M.; Hyatt, J.L.; Brumshtein, B.; Morton, C.L.; Wadkins, R.M.; Silman, I.; Sussman, J.L.; Potter, P.M. 2005: The 3D structure of the anticancer prodrug CPT-11 with Torpedo californica acetylcholinesterase rationalizes its inhibitory action on AChE and its hydrolysis by butyrylcholinesterase and carboxylesterase. Chemico-Biological Interactions 157-158: 153-157

Jójárt, B.áz.; Martinek, T.ás.A.; Márki, A.ád. 2005: The 3D structure of the binding pocket of the human oxytocin receptor for benzoxazine antagonists, determined by molecular docking, scoring functions and 3D-QSAR methods. Journal of Computer-Aided Molecular Design 19(5): 341-356

Congiu, T.; Radice, R.; Raspanti, M.; Reguzzoni, M. 2004: The 3D structure of the human urinary bladder mucosa: a scanning electron microscopy study. Journal of Submicroscopic Cytology and Pathology 36(1): 45-53

Liu, S.; Liu, F.; Yu, X.; Ding, G.; Xu, P.; Cao, J.; Jiang, Y. 2006: The 3D-QSAR analysis of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains on thymidylate synthase. Bioorganic and Medicinal Chemistry 14(5): 1425-1430

Choo, H-Young.Park.; Choi, S.; Jung, S-Hun.; Koh, H.Yeong.; Pae, A.Nim. 2003: The 3D-QSAR study of antitumor arylsulfonylimidazolidinone derivatives by CoMFA and CoMSIA. Bioorganic and Medicinal Chemistry 11(21): 4585-4589

Law, P.T.W.; Wong, C.-H.; Au, T.C.C.; Chuck, C.-P.; Kong, S.-K.; Chan, P.K.S.; To, K.-F.; Lo, A.W.I.; Chan, J.Y.W.; Suen, Y.-K.; Chan, H.Y.E.; Fung, K.-P.; Waye, M.M.Y.; Sung, J.J.Y.; Lo, Y.M.D.; Tsui, S.K.W. 2005: The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells. Journal of General Virology 86(Part 7): 1921-1930

Seiler, M.; Mehrle, A.; Poustka, A.; Wiemann, S. 2006: The 3of5 web application for complex and comprehensive pattern matching in protein sequences. Bmc Bioinformatics 7: 144

Hottenga, J.J.; Vanmolkot, K.R.J.; Kors, E.E.; Kheradmand Kia, S.; de Jong, P.T.V.M.; Haan, J.; Terwindt, G.M.; Frants, R.R.; Ferrari, M.D.; van den Maagdenberg, A.M.J.M. 2005: The 3p21.1-p21.3 hereditary vascular retinopathy locus increases the risk for Raynaud's phenomenon and migraine. Cephalalgia: An International Journal of Headache 25(12): 1168-1172

Ueda, K.; Kawashima, H.; Ohtani, S.; Deng, W-Guo.; Ravoori, M.; Bankson, J.; Gao, B.; Girard, L.; Minna, J.D.; Roth, J.A.; Kundra, V.; Ji, L. 2006: The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells. Cancer Research 66(19): 9682-9690

Roy, A.; Schneller, S.W.; Keith, K.A.; Hartline, C.B.; Kern, E.R. 2005: The 4',4'-difluoro analog of 5'-noraristeromycin: a new structural prototype for possible antiviral drug development toward orthopoxvirus and cytomegalovirus. Bioorganic and Medicinal Chemistry 13(14): 4443-4449

Brockman, H.L.; Momsen, M.M.; Brown, R.E.; He, L.; Chun, J.; Byun, H.-S.; Bittman, R. 2004: The 4,5-double bond of ceramide regulates its dipole potential, elastic properties, and packing behavior. Biophysical Journal 87(3): 1722-1731

Zheng, G.; Wang, B.; Chen, A. 2004: The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells. Journal of Immunology 173(4): 2428-2434

Flynn, M.R. 2004: The 4-parameter lognormal (SB) model of human exposure. Annals of Occupational Hygiene 48(7): 617-622

Chen, K.; Merino, C.; Sigrist, S.J.; Featherstone, D.E. 2005: The 4.1 protein coracle mediates subunit-selective anchoring of Drosophila glutamate receptors to the postsynaptic actin cytoskeleton. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 25(28): 6667-6675

Schenk, A.D.; Werten, P.J.L.; Scheuring, S.; de Groot, B.L.; Müller, S.A.; Stahlberg, H.; Philippsen, A.; Engel, A. 2005: The 4.5 A structure of human AQP2. Journal of Molecular Biology 350(2): 278-289

Diener, H-Christoph.; Ryan, R.; Sun, W.; Hettiarachchi, J. 2004: The 40-mg dose of eletriptan: comparative efficacy and tolerability versus sumatriptan 100 mg. European Journal of Neurology 11(2): 125-134

Caroppi, P.; Sinibaldi, F.; Santoni, E.; Howes, B.D.; Fiorucci, L.; Ferri, T.; Ascoli, F.; Smulevich, G.; Santucci, R. 2004: The 40s Omega-loop plays a critical role in the stability and the alkaline conformational transition of cytochrome c. Journal of Biological Inorganic Chemistry: Jbic: a Publication of the Society of Biological Inorganic Chemistry 9(8): 997-1006

Tyagi, S.; Surjit, M.; Lal, S.K. 2005: The 41-amino-acid C-terminal region of the hepatitis e virus ORF3 protein interacts with bikunin, a kunitz-type serine protease inhibitor. Journal of Virology 79(18): 12081-12087

Xie, Y.; Xu, K.; Dai, B.; Guo, Z.; Jiang, T.; Chen, H.; Qiu, Y. 2006: The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs. Oncogene 25(1): 70-78

Sarzani, R.; Cusi, D.; Salvi, F.; Barlassina, C.; Macciardi, F.; Pietrucci, F.; Cola, G.; Catalini, R.; Dal Fiume, C.; Dessì-Fulgheri, P.; Rappelli, A. 2006: The 460Trp allele of alpha-adducin increases carotid intima-media thickness in young adult males. Journal of Hypertension 24(4): 697-703

Poláková, Kína.; Kuba, D.; Russ, Gáv. 2004: The 4H84 monoclonal antibody detecting beta2m free nonclassical HLA-G molecules also binds to free heavy chains of classical HLA class I antigens present on activated lymphocytes. Human Immunology 65(2): 157-162

Tam, R.; Smith, K.P.; Lawrence, J.B. 2004: The 4q subtelomere harboring the FSHD locus is specifically anchored with peripheral heterochromatin unlike most human telomeres. Journal of Cell Biology 167(2): 269-279

Casadio, R. 2003: The 4th Bologna Winter School: hot topics in structural genomics. Comparative and Functional Genomics 4(4): 394-396

Charbonnier, F.ço.; Baert-Desurmont, S.; Liang, P.; Di Fiore, F.; Martin, C.; Frerot, S.; Olschwang, S.; Wang, Q.; Buisine, M.-P.; Gilbert, B.; Nilbert, M.; Lindblom, A.; Frebourg, T. 2005: The 5' region of the MSH2 gene involved in hereditary non-polyposis colorectal cancer contains a high density of recombinogenic sequences. Human Mutation 26(3): 255-261

Hawthorne, S.K.; Busanelli, R.R.; Kleene, K.C. 2006: The 5' UTR and 3' UTR of the sperm mitochondria-associated cysteine-rich protein mRNA regulate translation in spermatids by multiple mechanisms in transgenic mice. Developmental Biology 297(1): 118-126

Ace, C.I.; Okulicz, W.C. 2005: The 5' flanking region of the Rhesus monkey H3 (DMBT1) gene contains putative progesterone response elements. Dna and Cell Biology 24(6): 345-349

Rueda, D.; Hsieh, J.; Day-Storms, J.J.; Fierke, C.A.; Walter, N.G. 2005: The 5' leader of precursor tRNAAsp bound to the Bacillus subtilis RNase P holoenzyme has an extended conformation. Biochemistry 44(49): 16130-16139

Minczuk, M.; Lilpop, J.; Boros, J.; Stepien, P.P. 2005: The 5' region of the human hSUV3 gene encoding mitochondrial DNA and RNA helicase: promoter characterization and alternative pre-mRNA splicing. Biochimica et Biophysica Acta 1729(2): 81-87

Jin, H.; Xu, J.; Qian, F.; Du, L.; Tan, C.Y.; Lin, Z.; Peng, J.; Wen, Z. 2006: The 5' zebrafish scl promoter targets transcription to the brain, spinal cord, and hematopoietic and endothelial progenitors. Developmental Dynamics: An Official Publication of the American Association of Anatomists 235(1): 60-67

Osher, E.; Weisinger, G.; Limor, R.; Tordjman, K.; Stern, N. 2006: The 5 lipoxygenase system in the vasculature: emerging role in health and disease. Molecular and Cellular Endocrinology 252(1-2): 201-206

Coleman, J.E.; Wu, K.; Fülle, H.Jürgen.; Semple-Rowland, S.L. 2004: The 5' flanking sequence of the human retGC1 gene acquires a photoreceptor cell restricted activity pattern over the course of retinal development. Molecular Vision 10: 720-727

Shen, A.; Higgins, D.E. 2005: The 5' untranslated region-mediated enhancement of intracellular listeriolysin O production is required for Listeria monocytogenes pathogenicity. Molecular Microbiology 57(5): 1460-1473

Barnes, B.R.; Marklund, S.; Steiler, T.L.; Walter, M.; Hjälm, Göran.; Amarger, V.; Mahlapuu, M.; Leng, Y.; Johansson, C.; Galuska, D.; Lindgren, K.; Abrink, M.; Stapleton, D.; Zierath, J.R.; Andersson, L. 2004: The 5'-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. Journal of Biological Chemistry 279(37): 38441-38447

Yusufzai, T.M.; Felsenfeld, G. 2004: The 5'-HS4 chicken beta-globin insulator is a CTCF-dependent nuclear matrix-associated element. Proceedings of the National Academy of Sciences of the United States of America 101(23): 8620-8624

Satoh, J.; Kato, K.; Shinmyo, A. 2004: The 5'-untranslated region of the tobacco alcohol dehydrogenase gene functions as an effective translational enhancer in plant. Journal of Bioscience and Bioengineering 98(1): 1-8

Xu, M.; Cheng, N.; Gui, L.; Lai, M.; Wang, Y.; Xia, D.; Rui, M.; Zhang, Y.; Ma, D. 2004: The 5'-upstream region of human programmed cell death 5 gene contains a highly active TATA-less promoter that is up-regulated by etoposide. Gene 329: 39-49

Brown, K.S.; Kluijtmans, L.A.J.; Young, I.S.; Murray, L.; McMaster, D.; Woodside, J.V.; Yarnell, J.W.G.; Boreham, C.A.; McNulty, H.; Strain, J.J.; McPartlin, J.; Scott, J.M.; Mitchell, L.E.; Whitehead, A.S. 2004: The 5,10-methylenetetrahydrofolate reductase C677T polymorphism interacts with smoking to increase homocysteine. Atherosclerosis 174(2): 315-322

Katow, H.; Yaguchi, S.; Kiyomoto, M.; Washio, M. 2004: The 5-HT receptor cell is a new member of secondary mesenchyme cell descendants and forms a major blastocoelar network in sea urchin larvae. Mechanisms of Development 121(4): 325-337

Fioravante, D.; Smolen, P.D.; Byrne, J.H. 2006: The 5-HT- and FMRFa-activated signaling pathways interact at the level of the Erk MAPK cascade: potential inhibitory constraints on memory formation. Neuroscience Letters 396(3): 235-240

Calcagno, E.; Carli, M.; Invernizzi, R.W. 2006: The 5-HT(1A) receptor agonist 8-OH-DPAT prevents prefrontocortical glutamate and serotonin release in response to blockade of cortical NMDA receptors. Journal of Neurochemistry 96(3): 853-860

Sakaue, M.; Ago, Y.; Baba, A.; Matsuda, T. 2003: The 5-HT1A receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice. Psychopharmacology 170(1): 73-79

Carey, R.J.; Depalma, G.; Damianopoulos, E.; Müller, C.P.; Huston, J.P. 2004: The 5-HT1A receptor and behavioral stimulation in the rat: effects of 8-OHDPAT on spontaneous and cocaine-induced behavior. Psychopharmacology 177(1-2): 46-54

Pitsikas, N.; Tsitsirigou, S.; Zisopoulou, S.; Sakellaridis, N. 2005: The 5-HT1A receptor and recognition memory. Possible modulation of its behavioral effects by the nitrergic system. Behavioural Brain Research 159(2): 287-293

Reissig, C.J.; Eckler, J.R.; Rabin, R.A.; Winter, J.C. 2005: The 5-HT1A receptor and the stimulus effects of LSD in the rat. Psychopharmacology 182(2): 197-204

Andrews, C.M.; Kung, H.F.; Lucki, I. 2005: The 5-HT1A receptor modulates the effects of cocaine on extracellular serotonin and dopamine levels in the nucleus accumbens. European Journal of Pharmacology 508(1-3): 123-130

Higgins, G.A.; Enderlin, M.; Haman, M.; Fletcher, P.J. 2003: The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism. Psychopharmacology 170(3): 309-319

Doly, Séphane.; Madeira, A.; Fischer, J.; Brisorgueil, M-Jeanne.; Daval, G.; Bernard, R.; Vergé, D.; Conrath, M. 2004: The 5-HT2A receptor is widely distributed in the rat spinal cord and mainly localized at the plasma membrane of postsynaptic neurons. Journal of Comparative Neurology 472(4): 496-511

Sonier, B.; Arseneault, M.; Lavigne, C.; Ouellette, R.J.; Vaillancourt, C. 2006: The 5-HT2A serotoninergic receptor is expressed in the MCF-7 human breast cancer cell line and reveals a mitogenic effect of serotonin. Biochemical and Biophysical Research Communications 343(4): 1053-1059

McCullough, J.L.; Armstrong, S.R.; Hegde, S.S.; Beattie, D.T. 2006: The 5-HT2B antagonist and 5-HT4 agonist activities of tegaserod in the anaesthetized rat. Pharmacological Research 53(4): 353-358

Pitsikas, N.; Sakellaridis, N. 2005: The 5-HT2C receptor antagonist RO 60-0491 counteracts rats' retention deficits in a recognition memory task. Brain Research 1054(2): 200-202

Vega, L.d.l.; Muñoz, E.; Calzado, M.A.; Lieb, K.; Candelario-Jalil, E.; Gschaidmeir, H.; Färber, L.; Mueller, W.; Stratz, T.; Fiebich, B.L. 2005: The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway. Biochemical Pharmacology 70(3): 369-380

Oatway, M.A.; Chen, Y.; Weaver, L.C. 2004: The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury. Pain 110(1-2): 259-268

Das, P.; Dillon, G.H. 2003: The 5-HT3B subunit confers reduced sensitivity to picrotoxin when co-expressed with the 5-HT3A receptor. Brain Research. Molecular Brain Research 119(2): 207-212

Van Lelyveld, N.; Ter Linde, J.; Baron, A.; Mundt, M.; Wajs, E.; Samsom, M. 2006: The 5-HT4 antagonist R216073 does not affect gastric motor and sensory function in patients with functional dyspepsia. Alimentary Pharmacology and Therapeutics 24(4): 669-677

Lötsch, J.ör.; Skarke, C.; Schneider, A.; Hummel, T.; Geisslinger, G. 2005: The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression. Clinical Pharmacology and Therapeutics 78(3): 278-287

Houkin, K.; Nakayama, N.; Nonaka, T.; Koyanagi, I. 2006: The 5-hydroxytryptamine2A receptor antagonist sarpogrelate hydrochloride inhibits acute platelet aggregation in injured endothelium. Journal of International Medical Research 34(1): 65-72

Kemp, A.; Manahan-Vaughan, D. 2005: The 5-hydroxytryptamine4 receptor exhibits frequency-dependent properties in synaptic plasticity and behavioural metaplasticity in the hippocampal CA1 region in vivo. Cerebral Cortex 15(7): 1037-1043

Hoskin, K.L.; Lambert, G.A.; Donaldson, C.; Zagami, A.S. 2004: The 5-hydroxytryptamine1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat. Brain Research 998(1): 91-99

Lötzer, K.; Funk, C.D.; Habenicht, A.J.R. 2005: The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis. Biochimica et Biophysica Acta 1736(1): 30-37

Li, H.-Y.; Jin, Y.; Morisseau, C.; Hammock, B.D.; Long, Y.-Q. 2006: The 5-substituted piperazine as a novel secondary pharmacophore greatly improving the physical properties of urea-based inhibitors of soluble epoxide hydrolase. Bioorganic and Medicinal Chemistry 14(19): 6586-6592

Miyazaki, M.; Kiyohara, Y.; Yoshida, A.; Iida, M.; Nose, Y.; Ishibashi, T. 2005: The 5-year incidence and risk factors for age-related maculopathy in a general Japanese population: the Hisayama study. IOVS Investigative Ophthalmology and Visual Science 46(6): 1907-1910

Metaxa-Mariatou, V.; Vakalis, N.; Gazouli, M.; Nasioulas, G. 2004: The 500-base-pair fragment of the putative gene RvD1-Rv2031c is also present in the genome of Mycobacterium tuberculosis. In Vivo 18(1): 33-35

Hoppmann, P.; Koch, W.; Schömig, A.; Kastrati, A. 2004: The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions. European Heart Journal 25(4): 335-341

Ramos, A.J.; Rubio, M.ía.D.; Defagot, C.; Hischberg, L.; Villar, M.J.; Brusco, A. 2004: The 5HT1A receptor agonist, 8-OH-DPAT, protects neurons and reduces astroglial reaction after ischemic damage caused by cortical devascularization. Brain Research 1030(2): 201-220

Gonda, X.; Rihmer, Z.; Zsombok, T.; Bagdy, G.; Akiskal, K.K.; Akiskal, H.S. 2006: The 5HTTLPR polymorphism of the serotonin transporter gene is associated with affective temperaments as measured by TEMPS-A. Journal of Affective Disorders 91(2-3): 125-131

Allemand, Fédéric.; Mathy, N.; Brechemier-Baey, D.; Condon, Cán. 2005: The 5S rRNA maturase, ribonuclease M5, is a Toprim domain family member. Nucleic Acids Research 33(13): 4368-4376

Oliveira, I.O.; Lhullier, C.; Brum, I.S.; Spritzer, P.M. 2003: The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals. Brazilian Journal of Medical and Biological Research 36(10): 1447-1454

Defrate, L.E.; Papannagari, R.; Gill, T.J.; Moses, J.M.; Pathare, N.P.; Li, G. 2006: The 6 degrees of freedom kinematics of the knee after anterior cruciate ligament deficiency: an in vivo imaging analysis. American Journal of Sports Medicine 34(8): 1240-1246

Kobzová, J.; Vignerová, J.; Bláha, P.; Krejcovský, L.; Riedlová, J. 2004: The 6th nationwide anthropological survey of children and adolescents in the Czech Republic in 2001. Central European Journal of Public Health 12(3): 126-130

Cucinotta, V.; Giuffrida, A.; Maccarrone, G.; Messina, M.; Puglisi, A.; Torrisi, A.; Vecchio, G. 2005: The 6-derivative of beta-cyclodextrin with succinic acid: a new chiral selector for CD-EKC. Journal of Pharmaceutical and Biomedical Analysis 37(5): 1009-1014

Frost, A.E.; Langleben, D.; Oudiz, R.; Hill, N.; Horn, E.; McLaughlin, V.; Robbins, I.M.; Shapiro, S.; Tapson, V.F.; Zwicke, D.; DeMarco, T.; Schilz, R.; Rubenfire, M.; Barst, R.J. 2005: The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect. Vascular Pharmacology 43(1): 36-39

Cheetham, C.; Taylor, R.; Burke, V.; O'Driscoll, G.; Green, D.J. 2005: The 6-minute walk test does not reliably detect changes in functional capacity of patients awaiting cardiac transplantation. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 24(7): 848-853

Schlüter, A.; Heuer, H.; Szczepanowski, R.; Forney, L.J.; Thomas, C.M.; Pühler, A.; Top, E.M. 2003: The 64 508 bp IncP-1beta antibiotic multiresistance plasmid pB10 isolated from a waste-water treatment plant provides evidence for recombination between members of different branches of the IncP-1beta group. Microbiology 149(Pt 11): 3139-3153

Berno, V.; Porrini, D.; Castiglioni, F.; Campiglio, M.; Casalini, P.; Pupa, S.M.; Balsari, A.; Ménard, S.; Tagliabue, E. 2005: The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1. Endocrine-Related Cancer 12(2): 393-406

Lee, J.Eun.; Kim, Y.Jung.; Kim, J.Youl.; Lee, W.Taek.; Yenari, M.A.; Giffard, R.G. 2004: The 70 kDa heat shock protein suppresses matrix metalloproteinases in astrocytes. Neuroreport 15(3): 499-502

Kose, S.; Furuta, M.; Koike, M.; Yoneda, Y.; Imamoto, N. 2005: The 70-kD heat shock cognate protein (hsc70) facilitates the nuclear export of the import receptors. Journal of Cell Biology 171(1): 19-25

Xu, R.; Zhao, H.; Dinkins, R.D.; Cheng, X.; Carberry, G.; Li, Q.Q. 2006: The 73 kD subunit of the cleavage and polyadenylation specificity factor (CPSF) complex affects reproductive development in Arabidopsis. Plant Molecular Biology 61(4-5): 799-815

Ding, Y.; Li, M.; Zhang, J.; Li, N.; Xia, Z.; Hu, Y.; Wang, S.; Fan, G.-H. 2006: The 73-kDa heat shock cognate protein is a CXCR4 binding protein that regulates the receptor endocytosis and the receptor-mediated chemotaxis. Molecular Pharmacology 69(4): 1269-1279

Toompuu, M.; Levinger, L.L.; Nadal, A.; Gomez, J.; Jacobs, H.T. 2004: The 7472insC mtDNA mutation impairs 5' and 3' processing of tRNA(Ser(UCN)). Biochemical and Biophysical Research Communications 322(3): 803-813

Timko, C.; Finney, J.W.; Moos, R.H. 2005: The 8-year course of alcohol abuse: gender differences in social context and coping. Alcoholism Clinical and Experimental Research 29(4): 612-621

Laki, J.; Laki, Ián.; Németh, K.; Ujhelyi, R.; Bede, O.; Endreffy, E.; Bolbás, K.; Gyurkovits, Kálmán.; Csiszér, E.; Sólyom, E.; Dobra, G.; Halász, A.; Pozsonyi, E.; Rajczy, K.; Prohászka, Zán.; Fekete, Görgy.; Füst, G. 2006: The 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosis. International Immunology 18(11): 1585-1590

Biller, C.Katarina.; Antonacci, A.C.; Pelletier, S.; Homel, P.; Spann, C.; Cunningham, M.J.; Eavey, R.D. 2006: The 80-hour work guidelines and resident survey perceptions of quality. Journal of surgical research 135(2): 275-281

Bonilla, C.; Boxill, L-Anne.; Donald, S.Ann.Mc.; Williams, T.; Sylvester, N.; Parra, E.J.; Dios, S.; Norton, H.L.; Shriver, M.D.; Kittles, R.A. 2005: The 8818G allele of the agouti signaling protein (ASIP) gene is ancestral and is associated with darker skin color in African Americans. Human Genetics 116(5): 402-406

Lapu-Bula, R.; Quarshie, A.; Lyn, D.; Oduwole, A.; Pack, C.; Morgan, J.; Nkemdiche, S.; Igho-Pemu, P.; Onwuanyi, A.; Li, R.; Ofili, E. 2005: The 894T allele of endothelial nitric oxide synthase gene is related to left ventricular mass in African Americans with high-normal blood pressure. Journal of the National Medical Association 97(2): 197-205

Peterson, L.F.; Zhang, D.E. 2004: The 8; 21 translocation in leukemogenesis. Oncogene 23(24): 4255-4262

Amieva, Hélène.; Jacqmin-Gadda, Hélène.; Orgogozo, J-Marc.; Le Carret, N.; Helmer, C.; Letenneur, L.; Barberger-Gateau, P.; Fabrigoule, C.; Dartigues, J-François. 2005: The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain: a Journal of Neurology 128(Pt 5): 1093-1101

Grassadonia, A.; Tinari, N.; Fiorentino, B.; Suzuki, K.; Nakazato, M.; De Tursi, M.; Giuliani, C.; Napolitano, G.; Singer, D.S.; Iacobelli, S.; Kohn, L.D. 2004: The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides. Endocrinology 145(10): 4728-4736

Nowack, E.C.M.; Podola, B.ör.; Melkonian, M. 2005: The 96-well twin-layer system: a novel approach in the cultivation of microalgae. Protist 156(2): 239-251

Bozkulak, O.; Tabakoglu, H.Ozgur.; Aksoy, A.; Kurtkaya, O.; Sav, A.; Canbeyli, R.; Gulsoy, M. 2004: The 980-nm diode laser for brain surgery: histopathology and recovery period. Lasers in Medical Science 19(1): 41-47

Arao, K.; Yotsumoto, H.; Han, S-Young.; Nagao, K.; Yanagita, T. 2004: The 9cis,11trans,13cis isomer of conjugated linolenic acid reduces apolipoprotein B100 secretion and triacylglycerol synthesis in HepG2 cells. Bioscience Biotechnology and Biochemistry 68(12): 2643-2645

Hou, H.J.M.; Mauzerall, D. 2006: The A-Fx to F(A/B) step in synechocystis 6803 photosystem I is entropy driven. Journal of the American Chemical Society 128(5): 1580-1586

Yang, D.; Zhang, Y.; Nguyen, H.G.; Koupenova, M.; Chauhan, A.K.; Makitalo, M.; Jones, M.R.; St Hilaire, C.; Seldin, D.C.; Toselli, P.; Lamperti, E.; Schreiber, B.M.; Gavras, H.; Wagner, D.D.; Ravid, K. 2006: The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. Journal of Clinical Investigation 116(7): 1913-1923

Hosseini-Maaf, B.; Smart, E.; Chester, M.A.; Olsson, M.L. 2005: The Abantu phenotype in the ABO blood group system is due to a splice-site mutation in a hybrid between a new O1-like allelic lineage and the A2 allele. Vox Sanguinis 88(4): 256-264

Fei, G.-Z.; Svenungsson, E.; Frostegård, J.; Padyukov, L. 2004: The A-1087IL-10 allele is associated with cardiovascular disease in SLE. Atherosclerosis 177(2): 409-414

Chen-Yu-Juan; Zhang-Si-Zhong; Xiao-Cui-Ying; Tao-Da-Chang; He-Guo-Ping; Wang-Ying-Cheng; Liu-Yun-Qiang; Ma-Yong-Xin 2006: The A-204C polymorphism in CYP7A1 gene affects its promoter activity. Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao 22(6): 450-453

Kovár, J.; Suchánek, P.; Hubácek, J.A.; Poledne, R. 2004: The A-204C polymorphism in the cholesterol 7alpha-hydroxylase (CYP7A1) gene determines the cholesterolemia responsiveness to a high-fat diet. Physiological Research 53(5): 565-568

Rohrbacher, M.; Risch, A.; Kropp, S.; Chang-Claude, J. 2005: The A(-336C) insulin-like growth factor binding protein-3 promoter polymorphism is not a modulator of breast cancer risk in Caucasian women. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 14(1): 289-290

Thomas, S.E.; Deas, D. 2005: The A-OCDS predicts both craving and alcohol cue reactivity in adolescent alcoholics. Addictive Behaviors 30(9): 1638-1648

Gu, W.; Gencic, S.; Cramer, S.P.; Grahame, D.A. 2003: The A-cluster in subunit beta of the acetyl-CoA decarbonylase/synthase complex from Methanosarcina thermophila: Ni and Fe K-edge XANES and EXAFS analyses. Journal of the American Chemical Society 125(50): 15343-15351

Nishiyama, T.; Hanaoka, K. 2004: The A-line ARX index may be a more sensitive detector of arousal than the bispectral index during propofol-fentanyl-nitrous oxide anesthesia: a preliminary investigation. Canadian Journal of Anaesthesia 51(6): 539-544

Ambudkar, S.V.; Kim, I.-W.; Xia, D.; Sauna, Z.E. 2006: The A-loop, a novel conserved aromatic acid subdomain upstream of the Walker a motif in ABC transporters, is critical for ATP binding. Febs Letters 580(4): 1049-1055

Lescoute, A.; Westhof, E. 2006: The A-minor motifs in the decoding recognition process. Biochimie 88(8): 993-999

Korn, D.; Ebbighausen, V.; Bockwinkel, J.; Klug, C. 2003: The A-mode sutural ontogeny in prolecanitid ammonoids. Palaeontology 46(6): 1123-1132

Torgersen, M.L.; Lauvrak, S.U.; Sandvig, K. 2005: The A-subunit of surface-bound Shiga toxin stimulates clathrin-dependent uptake of the toxin. Febs Journal 272(16): 4103-4113

Santos, A.D.; McIntosh, J.M.; Hillyard, D.R.; Cruz, L.J.; Olivera, B.M. 2004: The A-superfamily of conotoxins: structural and functional divergence. Journal of Biological Chemistry 279(17): 17596-17606

Wolgemuth, D.J.; Lele, K.M.; Jobanputra, V.; Salazar, G. 2004: The A-type cyclins and the meiotic cell cycle in mammalian male germ cells. International Journal of Andrology 27(4): 192-199

Aubrecht, G.; Schifter, H.; Plass, J.; Weigl, S.; Allan, D.G. 2004: The A.G.H. Rudatis bird (Aves) collection (1904-1906) from Natal (KwaZulu-Natal) at the Museum of Upper Austria. Durban Museum Novitates 29: 31-49

Ponce, G.; Jimenez-Arriero, M.A.; Rubio, G.; Hoenicka, J.; Ampuero, I.; Ramos, J.A.; Palomo, T. 2003: The A1 allele of the DRD2 gene (TaqI A polymorphisms) is associated with antisocial personality in a sample of alcohol-dependent patients. European Psychiatry: the Journal of the Association of European Psychiatrists 18(7): 356-360

Laakso, A.; Pohjalainen, T.; Bergman, Jörgen.; Kajander, J.; Haaparanta, M.; Solin, O.; Syvälahti, E.; Hietala, J. 2005: The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects. Pharmacogenetics and Genomics 15(6): 387-391

Díez, J.; Laviades, Cón.; Orbe, J.; Zalba, G.; López, Bña.; González, A.; Mayor, G.; Páramo, Jé.A.; Beloqui, O. 2003: The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives. Journal of Hypertension 21(11): 2085-2092

Dos Santos, J.M.ça.; Abdalla, C.áu.B.; Campos, M.ár.; Santos-Rebouças, C.ín.B.; Pimentel, M.ár.M.G.ça. 2005: The A140V mutation in the MECP2 gene is not a common etiological factor among Brazilian mentally retarded males. Neuroscience Letters 379(1): 13-16

Bayfield, M.A.; Thompson, J.; Dahlberg, A.E. 2004: The A2453-C2499 wobble base pair in Escherichia coli 23S ribosomal RNA is responsible for pH sensitivity of the peptidyltransferase active site conformation. Nucleic Acids Research 32(18): 5512-5518

Laudadio, M.A.; Psarropoulou, C. 2004: The A3 adenosine receptor agonist 2-Cl-IB-MECA facilitates epileptiform discharges in the CA3 area of immature rat hippocampal slices. Epilepsy Research 59(2-3): 83-94

Werner, R.; Holterhus, P.-M.; Binder, G.; Schwarz, H.-P.; Morlot, M.; Struve, D.; Marschke, C.; Hiort, O. 2006: The A645D mutation in the hinge region of the human androgen receptor (AR) gene modulates AR activity, depending on the context of the polymorphic glutamine and glycine repeats. Journal of Clinical Endocrinology and Metabolism 91(9): 3515-3520

Kadura, S.; He, X.; Vanoosthuyse, V.; Hardwick, K.G.; Sazer, S. 2005: The A78V mutation in the Mad3-like domain of Schizosaccharomyces pombe Bub1p perturbs nuclear accumulation and kinetochore targeting of Bub1p, Bub3p, and Mad3p and spindle assembly checkpoint function. Molecular Biology of the Cell 16(1): 385-395

Limosin, F.éd.ér.; Loze, J.-Y.; Boni, C.; Fedeli, L.-P.; Hamon, M.; Rouillon, F.éd.ér.; Adès, J.; Gorwood, P. 2004: The A9 allele of the dopamine transporter gene increases the risk of visual hallucinations during alcohol withdrawal in alcohol-dependent women. Neuroscience Letters 362(2): 91-94

Li, G.; Zhao, G.; Zhou, X.; Schindelin, H.; Lennarz, W.J. 2006: The AAA ATPase p97 links peptide N-glycanase to the endoplasmic reticulum-associated E3 ligase autocrine motility factor receptor. Proceedings of the National Academy of Sciences of the United States of America 103(22): 8348-8353

Bruderer, R.M.; Brasseur, C.; Meyer, H.H. 2004: The AAA ATPase p97/VCP interacts with its alternative co-factors, Ufd1-Npl4 and p47, through a common bipartite binding mechanism. Journal of Biological Chemistry 279(48): 49609-49616

Cao, K.; Nakajima, R.; Meyer, H.H.; Zheng, Y. 2003: The AAA-ATPase Cdc48/p97 regulates spindle disassembly at the end of mitosis. Cell 115(3): 355-367

Nagahama, M.; Yamazoe, T.; Hara, Y.; Tani, K.; Tsuji, A.; Tagaya, M. 2006: The AAA-ATPase NVL2 is a component of pre-ribosomal particles that interacts with the DExD/H-box RNA helicase DOB1. Biochemical and Biophysical Research Communications 346(3): 1075-1082

Maeda, R.K.; Karch, F.ço. 2006: The ABC of the BX-C: the bithorax complex explained. Development 133(8): 1413-1422

Krishnamurthy, P.; Schuetz, J.D. 2005: The ABC transporter Abcg2/Bcrp: role in hypoxia mediated survival. Biometals: An International Journal on the Role of Metal Ions in Biology Biochemistry and Medicine 18(4): 349-358

Ravaud, S.ép.; Do Cao, M.-A.; Jidenko, M.; Ebel, C.; Le Maire, M.; Jault, J.-M.; Di Pietro, A.; Haser, R.; Aghajari, N. 2006: The ABC transporter BmrA from Bacillus subtilis is a functional dimer when in a detergent-solubilized state. Biochemical Journal 395(2): 345-353

Jones, P.M.; George, A.M. 2004: The ABC transporter structure and mechanism: perspectives on recent research. Cellular and Molecular Life Sciences: Cmls 61(6): 682-699

Lucas, K.Killermann.; Dennis, E.A. 2004: The ABC's of Group IV cytosolic phospholipase A2. Biochimica et Biophysica Acta 1636(2-3): 213-218

Howe, A.E.; Arnell, K.M.; Klein, R.M.; Joanisse, M.F.; Tannock, R. 2006: The ABCs of computerized naming: equivalency, reliability, and predictive validity of a computerized rapid automatized naming (RAN) task. Journal of Neuroscience Methods 151(1): 30-37

Chan, L.M.S.; Lowes, S.; Hirst, B.H. 2004: The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 21(1): 25-51

Abele, R.; Tampé, R. 2004: The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing. Physiology 19: 216-224

Hediger, M.A.; Romero, M.F.; Peng, J.B.; Rolfs, A.; Takanaga, H.; Bruford, E.A. 2004: The ABCs of solute carriers: Physiological, pathological and therapeutic implications of human membrane transport proteins. Pfluegers Archiv European Journal of Physiology 447(5): 465-468

Tirado, I.; Mateo, Jé.; Soria, Jé.Manuel.; Oliver, A.; Martínez-Sánchez, E.; Vallvé, C.; Borrell, M.; Urrutia, T.; Fontcuberta, J. 2005: The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thrombosis and Haemostasis 93(3): 468-474

Villuendas, G.; Botella-Carretero, J.é I.; López-Bermejo, A.; Gubern, C.; Ricart, W.; Fernández-Real, J.é M.; San Millán, J.é L.; Escobar-Morreale, H.éc.F. 2006: The ACAA-insertion/deletion polymorphism at the 3' UTR of the IGF-Ii receptor gene is associated with type 2 diabetes and surrogate markers of insulin resistance. European Journal of Endocrinology 155(2): 331-336

Hutter-Paier, B.; Huttunen, H.J.; Puglielli, L.; Eckman, C.B.; Kim, D.Yeon.; Hofmeister, A.; Moir, R.D.; Domnitz, S.B.; Frosch, M.P.; Windisch, M.; Kovacs, D.M. 2004: The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. Neuron 44(2): 227-238

Burnett, J.R.; Telford, D.E.; Barrett, P.H.R.; Huff, M.W. 2005: The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs. Biochimica et Biophysica Acta 1738(1-3): 10-18

Yoshida, H.; Wang, K.L-C.; Chang, C-Man.; Mori, K.; Uchida, E.; Ecker, J.R. 2006: The ACC synthase TOE sequence is required for interaction with ETO1 family proteins and destabilization of target proteins. Plant molecular biology 62(3): 427-437

Wells, P.S.; Rodger, M.A.; Forgie, M.A.; Langlois, N.J.; Armstrong, L.; Carson, N.L.; Jaffey, J. 2003: The ACE D/D genotype is protective against the development of idiopathic deep vein thrombosis and pulmonary embolism. Thrombosis and Haemostasis 90(5): 829-834

Collins, M.; Xenophontos, S.L.; Cariolou, M.A.; Mokone, G.G.; Hudson, D.E.; Anastasiades, L.; Noakes, T.D. 2004: The ACE gene and endurance performance during the South African Ironman Triathlons. Medicine and Science in Sports and Exercise 36(8): 1314-1320

Tsianos, G.; Sanders, J.; Dhamrait, S.; Humphries, S.; Grant, S.; Montgomery, H. 2004: The ACE gene insertion/deletion polymorphism and elite endurance swimming. European Journal of Applied Physiology 92(3): 360-362

Pierce, D.W.; Barnett, T.P.; Tokmakian, R.; Semtner, A.; Maltrud, M.; Lysne, J.; Craig, A. 2004: The ACPI project, element 1: Initializing a coupled climate model from observed conditions. Climatic Change 62(1-3): 13-28

Grant, G.A. 2006: The ACT domain: a small molecule binding domain and its role as a common regulatory element. Journal of Biological Chemistry 281(45): 33825-33829

Yehuda, R.; Golier, J.A.; Halligan, S.L.; Meaney, M.; Bierer, L.M. 2004: The ACTH response to dexamethasone in PTSD. American Journal of Psychiatry 161(8): 1397-1403

Galvin, J.E.; Roe, C.M.; Powlishta, K.K.; Coats, M.A.; Muich, S.J.; Grant, E.; Miller, J.P.; Storandt, M.; Morris, J.C. 2005: The AD8: a brief informant interview to detect dementia. Neurology 65(4): 559-564

Albrecht, S.; Wang, S.; Holz, A.; Bergter, A.; Paululat, A. 2006: The ADAM metalloprotease Kuzbanian is crucial for proper heart formation in Drosophila melanogaster. Mechanisms of Development 123(5): 372-387

Porter, S.; Clark, I.M.; Kevorkian, L.; Edwards, D.R. 2005: The ADAMTS metalloproteinases. Biochemical Journal 386(Pt 1): 15-27

Kliche, S.; Breitling, D.; Togni, M.; Pusch, R.; Heuer, K.; Wang, X.; Freund, C.; Kasirer-Friede, A.; Menasche, G.; Koretzky, G.A.; Schraven, B. 2006: The ADAP/SKAP55 signaling module regulates T-cell receptor-mediated integrin activation through plasma membrane targeting of Rap1. Molecular and Cellular Biology 26(19): 7130-7144

Peters, E.S.; McClean, M.D.; Liu, M.; Eisen, E.A.; Mueller, N.; Kelsey, K.T. 2005: The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 14(2): 476-482

Owens, J.A. 2005: The ADHD and sleep conundrum: a review. Journal of Developmental and Behavioral Pediatrics: Jdbp 26(4): 312-322

Yep, A.; Ballicora, M.A.; Preiss, J. 2006: The ADP-glucose binding site of the Escherichia coli glycogen synthase. Archives of Biochemistry and Biophysics 453(2): 188-196

Bejar, C.M.; Ballicora, M.A.; Gómez-Casati, D.F.; Iglesias, A.A.; Preiss, J. 2004: The ADP-glucose pyrophosphorylase from Escherichia coli comprises two tightly bound distinct domains. Febs Letters 573(1-3): 99-104

Liu, H.; Zhang, H.; Iles, K.E.; Rinna, A.; Merrill, G.; Yodoi, J.; Torres, M.; Forman, H.Jay. 2006: The ADP-stimulated NADPH oxidase activates the ASK-1/MKK4/JNK pathway in alveolar macrophages. Free Radical Research 40(8): 865-874

Lockett, K.L.; Hall, M.Craig.; Xu, J.; Zheng, S.Lilly.; Berwick, M.; Chuang, S-Chun.; Clark, P.E.; Cramer, S.D.; Lohman, K.; Hu, J.J. 2004: The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Research 64(17): 6344-6348

Holappa, K.; Muñoz, M.T.; Egea, G.; Kellokumpu, S. 2004: The AE2 anion exchanger is necessary for the structural integrity of the Golgi apparatus in mammalian cells. Febs Letters 564(1-2): 97-103

Holmes, L.B.; Wyszynski, D.F.; Lieberman, E. 2004: The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Archives of Neurology 61(5): 673-678

Clark, D.A.; Biron, D.; Sengupta, P.; Samuel, A.D.T. 2006: The AFD sensory neurons encode multiple functions underlying thermotactic behavior in Caenorhabditis elegans. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 26(28): 7444-7451

Shelton, R.J. 2004: The AFFIRM study: approaches to control rate in atrial fibrillation. Journal of the American College of Cardiology 44(12): 2418; author reply 2418-9

Shushan, A.; Rojansky, N.; Laufer, N.; Klein, B.Y.; Shlomai, Z.; Levitzki, R.; Hartzstark, Z.; Ben-Bassat, H. 2004: The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth. Human Reproduction 19(9): 1957-1967

Baumann, P.; Hiemke, C.; Ulrich, S.; Eckermann, G.; Gaertner, I.; Gerlach, M.; Kuss, H-J.; Laux, G.; Müller-Oerlinghausen, B.; Rao, M.L.; Riederer, P.; Zernig, G. 2004: The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 37(6): 243-265

Yu, H-min.; Lin, S-guang.; Zhang, Y-qing.; Ma, W-jun.; Liu, G-zhang. 2005: The AGT genotype affects the antihypertensive effects of benazepril. Zhonghua Xin Xue Guan Bing Za Zhi 33(9): 819-823

Neuhaus, K.; Anastasov, N.; Kaberdin, V.; Francis, K.P.; Miller, V.L.; Scherer, S. 2003: The AGUAAA motif in cspA1/A2 mRNA is important for adaptation of Yersinia enterocolitica to grow at low temperature. Molecular Microbiology 50(5): 1629-1645

Spurdle, A.B.; Antoniou, A.C.; Kelemen, L.; Holland, H.; Peock, S.; Cook, M.R.; Smith, P.L.; Greene, M.H.; Simard, J.; Plourde, M.; Southey, M.C.; Godwin, A.K.; Beck, J.; Miron, A.; Daly, M.B.; Santella, R.M.; Hopper, J.L.; John, E.M.; Andrulis, I.L.; Durocher, F.; Struewing, J.P.; Easton, D.F.; Chenevix-Trench, G. 2006: The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 15(1): 76-79

Noë, A.; Verhofstede, C.; Plum, J. 2004: The AIDS epidemic: the spread of a deadly disease in the biotech era. Journal of Biological Regulators and Homeostatic Agents 18(2): 178-182

Dunham, R.; Pagliardini, P.; Gordon, S.; Sumpter, B.; Engram, J.; Moanna, A.; Paiardini, M.; Mandl, J.N.; Lawson, B.; Garg, S.; McClure, H.M.; Xu, Y-Xian.; Ibegbu, C.; Easley, K.; Katz, N.; Pandrea, I.; Apetrei, C.; Sodora, D.L.; Staprans, S.I.; Feinberg, M.B.; Silvestri, G. 2006: The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus. Blood 108(1): 209-217

Agarwal, A.; Das, K.; Lerner, N.; Sathe, S.; Cicek, M.; Casey, G.; Sizemore, N. 2005: The AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-catenin. Oncogene 24(6): 1021-1031

Ginsberg, M.D.; Hill, M.D.; Palesch, Y.Y.; Ryckborst, K.J.; Tamariz, D. 2006: The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results. Stroke 37(8): 2100-2106

Palesch, Y.Y.; Hill, M.D.; Ryckborst, K.J.; Tamariz, D.; Ginsberg, M.D. 2006: The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis. Stroke 37(8): 2107-2114

Tojo, M.; Hamashima, Y.; Hanyu, A.; Kajimoto, T.; Saitoh, M.; Miyazono, K.; Node, M.; Imamura, T. 2005: The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-beta. Cancer Science 96(11): 791-800

Chrysant, S.G. 2003: The ALLHAT study: results and clinical implications. Qjm: Monthly Journal of the Association of Physicians 96(10): 771-773

Nygren, I.; Antonova, K.; Mattsson, P.; Askmark, H. 2005: The ALS/MND prevalence in Sweden estimated by riluzole sales statistics. Acta Neurologica Scandinavica 111(3): 180-184

Kaufmann, P.; Levy, G.; Thompson, J.L.P.; Delbene, M.L.; Battista, V.; Gordon, P.H.; Rowland, L.P.; Levin, B.; Mitsumoto, H. 2005: The ALSFRSr predicts survival time in an ALS clinic population. Neurology 64(1): 38-43

Shapiro, M.J.; Powell, P.; Ndubuizu, A.; Nzerem, C.; Shapiro, V.S. 2004: The ALX Src homology 2 domain is both necessary and sufficient to inhibit T cell receptor/CD28-mediated up-regulation of RE/AP. Journal of Biological Chemistry 279(39): 40647-40652

Tengs, T.O.; Ahmad, S.; Savage, J.M.; Moore, R.; Gage, E. 2005: The AMA proposal to mandate nicotine reduction in cigarettes: a simulation of the population health impacts. Preventive Medicine 40(2): 170-180

Schessl, C.; Rawat, V.P.S.; Cusan, M.; Deshpande, A.; Kohl, T.M.; Rosten, P.M.; Spiekermann, K.; Humphries, R.Keith.; Schnittger, S.; Kern, W.; Hiddemann, W.; Quintanilla-Martinez, L.; Bohlander, S.K.; Feuring-Buske, M.; Buske, C. 2005: The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice. Journal of Clinical Investigation 115(8): 2159-2168

Fowler, J.H.; Whalley, K.; Murray, T.; O'neill, M.J.; McCulloch, J. 2004: The AMPA receptor potentiator LY404187 increases cerebral glucose utilization and c-fos expression in the rat. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 24(10): 1098-1109

Hartmann, B.; Ahmadi, S.; Heppenstall, P.A.; Lewin, G.R.; Schott, C.; Borchardt, T.; Seeburg, P.H.; Zeilhofer, H.Ulrich.; Sprengel, R.; Kuner, R. 2004: The AMPA receptor subunits GluR-A and GluR-B reciprocally modulate spinal synaptic plasticity and inflammatory pain. Neuron 44(4): 637-650

Erdo, F.; Berzsenyi, P.ál.; Andrási, F. 2005: The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia. Brain Research Bulletin 66(1): 43-49

Raivich, G.; Bohatschek, M.; Da Costa, C.; Iwata, O.; Galiano, M.; Hristova, M.; Nateri, A.S.; Makwana, M.; Riera-Sans, L.ís.; Wolfer, D.P.; Lipp, H.-P.; Aguzzi, A.; Wagner, E.F.; Behrens, A. 2004: The AP-1 transcription factor c-Jun is required for efficient axonal regeneration. Neuron 43(1): 57-67

Moore-Carrasco, R.; García-Martínez, C.; Busquets, S.íl.; Ametller, E.; Barreiro, E.; López-Soriano, F.J.; Argilés, J.M. 2006: The AP-1/CJUN signaling cascade is involved in muscle differentiation: implications in muscle wasting during cancer cachexia. Febs Letters 580(2): 691-696

Rappoport, J.Z.; Taha, B.W.; Lemeer, S.; Benmerah, A.; Simon, S.M. 2003: The AP-2 complex is excluded from the dynamic population of plasma membrane-associated clathrin. Journal of Biological Chemistry 278(48): 47357-47360

Shim, J.; Lee, J. 2005: The AP-3 clathrin-associated complex is essential for embryonic and larval development in Caenorhabditis elegans. Molecules and Cells 19(3): 452-457

Karreth, F.; Hoebertz, A.; Scheuch, H.; Eferl, R.; Wagner, E.F. 2004: The AP1 transcription factor Fra2 is required for efficient cartilage development. Development 131(22): 5717-5725

Li, P.; Cunningham, K. 2005: The APA Style Converter: a Web-based interface for converting articles to APA style for publication. Behavior Research Methods 37(2): 219-223

Hahnloser, D.; Petersen, G.M.; Rabe, K.; Snow, K.; Lindor, N.M.; Boardman, L.; Koch, B.; Doescher, D.; Wang, L.; Steenblock, K.; Thibodeau, S.N. 2003: The APC E1317Q variant in adenomatous polyps and colorectal cancers. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 12(10): 1023-1028

Carroll, C.W.; Enquist-Newman, M.; Morgan, D.O. 2005: The APC subunit Doc1 promotes recognition of the substrate destruction box. Current Biology: Cb 15(1): 11-18

Hamada, F.; Bienz, M. 2004: The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF. Developmental Cell 7(5): 677-685

Sierra, J.; Yoshida, T.; Joazeiro, C.A.; Jones, K.A. 2006: The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes and Development 20(5): 586-600

Steigerwald, K.; Behbehani, G.K.; Combs, K.A.; Barton, M.C.; Groden, J. 2005: The APC tumor suppressor promotes transcription-independent apoptosis in vitro. Molecular Cancer Research: Mcr 3(2): 78-89

Chung, R.-H.; Hauser, E.R.; Martin, E.R. 2006: The APL test: extension to general nuclear families and haplotypes and examination of its robustness. Human Heredity 61(4): 189-199

Sun, Y.; Shi, J.; Zhang, S.; Tang, M.; Han, H.; Guo, Y.; Ma, C.; Liu, X.; Li, T. 2005: The APOC3 Ssti polymorphism is weakly associated with sporadic Alzheimer's disease in a Chinese population. Neuroscience Letters 380(3): 219-222

von Rotz, R.C.; Kohli, B.M.; Bosset, Jérôme.; Meier, M.; Suzuki, T.; Nitsch, R.M.; Konietzko, U. 2004: The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. Journal of Cell Science 117(Pt 19): 4435-4448

Gallagher, S.J.; Kefford, R.F.; Rizos, H. 2006: The ARF tumour suppressor. International Journal of Biochemistry and Cell Biology 38(10): 1637-1641

Wadhwa, R.; Sugihara, T.; Taira, K.; Kaul, S.C. 2004: The ARF-p53 senescence pathway in mouse and human cells. Histology and Histopathology 19(1): 311-316

Bousquet, J.; Bindslev-Jensen, C.; Canonica, G.W.; Fokkens, W.; Kim, H.; Kowalski, M.; Magnan, A.; Mullol, J.; van Cauwenberge, P. 2004: The ARIA/EAACi criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine. Allergy 59(Suppl 77): 4-16

André, M. 2004: The ARTEMIS European driving cycles for measuring car pollutant emissions. Science of the Total Environment 334-335: 73-84

Nawara, M.; Szczaluba, K.; Poirier, K.; Chrzanowska, K.; Pilch, J.; Bal, J.; Chelly, J.; Mazurczak, T. 2006: The ARX mutations: a frequent cause of X-linked mental retardation. American Journal of Medical Genetics. Part a 140(7): 727-732

Iyer, L.M.; Burroughs, A.M.; Aravind, L. 2006: The ASCH superfamily: novel domains with a fold related to the PUA domain and a potential role in RNA metabolism. Bioinformatics 22(3): 257-263

Hayakawa, T.; Matsuzawa, A.; Noguchi, T.; Takeda, K.; Ichijo, H. 2006: The ASK1-MAP kinase pathways in immune and stress responses. Microbes and Infection 8(4): 1098-1107

Phan, T.G.; Donnan, G.A.; Koga, M.; Mitchell, L.A.; Molan, M.; Fitt, G.; Chong, W.; Holt, M.; Reutens, D.C. 2006: The ASPECTS template is weighted in favor of the striatocapsular region. Neuroimage 31(2): 477-481

Scherf, F.; Brokx, J.; Wuyts, F.L.; Van de Heyning, P.H. 2006: The ASSR: clinical application in normal-hearing and hearing-impaired infants and adults, comparison with the click-evoked ABR and pure-tone audiometry. International Journal of Audiology 45(5): 281-286

Nyblom, H.; Björnsson, E.; Simrén, M.; Aldenborg, F.; Almer, S.; Olsson, R. 2006: The AST/ALT ratio as an indicator of cirrhosis in patients with PBC. Liver International: Official Journal of the International Association for the Study of the Liver 26(7): 840-845

Chandonia, J.-M.; Hon, G.; Walker, N.S.; Lo Conte, L.; Koehl, P.; Levitt, M.; Brenner, S.E. 2004: The ASTRAL Compendium in 2004. Nucleic Acids Research 32(Database Issue): D189-D192

Billet, S.; Bardin, S.; Tacine, R.; Clauser, E.; Conchon, S. 2006: The AT(1A) receptor '' gain-of-function '' mutant N111S/Delta 329 is both constitutively active and hyperreactive to angiotensin II. American Journal of Physiology Endocrinology and Metabolism 290(5): E840-E848

Duffy, S.; Jackson, T.L.; Lansdown, M.; Philips, K.; Wells, M.; Pollard, S.; Clack, G.; Coibion, M.; Bianco, A.R. 2006: The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment. Human Reproduction 21(2): 545-553

Duffy, S.; Jackson, T.L.; Lansdown, M.; Philips, K.; Wells, M.; Pollard, S.; Clack, G.; Coibion, M.; Bianco, A.R. 2005: The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy. Human Reproduction 20(1): 294-301